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introduction
Asthma is a chronic respiratory disease, typically characterized by recurrent symptoms 
such as wheeze and breathlessness. The Global Initiative for Asthma has described 
asthma as follows (1): asthma is a chronic inflammatory disorder of the airways. The 
chronic inflammation is associated with airway hyperresponsiveness that leads to recur-
rent episodes of wheezing, breathlessness, chest tightness, and coughing, particularly 
at night or in the early morning. These episodes are usually associated with widespread, 
but variable, airflow obstruction within the lung that is often reversible either spontane-
ously or with treatment.
This chapter successively describes the epidemiology of asthma, the establishment of 
a diagnosis of asthma and the emphasis is on the self-management of asthma. The topic 
of this thesis is the development and evaluation of an internet-based self-management 
support program. The aims of the studies are presented in the last section.
ePideMiology
Asthma is a common disease, affecting about 300 million people worldwide. The global 
prevalence ranges from 1 to 18% of the population in different countries (2). Based on 
Dutch primary care registries, the prevalence of asthma in the Netherlands is 3% in men 
and 3.5% in women, which represents more than 500 000 people. The number of newly 
diagnosed asthma patients in Dutch primary care is 7 per 1000 per year (3). 
Prevalence rates in children and adolescents are higher than in adults. Based on a 
positive answer to the question: “Have you (has your child) had wheezing or whistling 
in the chest in the past 12 months?”, the prevalence of asthma symptoms in Western 
Europe is 7-20% among children aged 6-7 years, and 8-30% in the 13-14 year age group 
(4). The prevalence of asthma in children seems to decrease. A Dutch study showed that 
wheeze in 8-9 year old children decreased from 13.4% in 1989 to 9.1% in 2001 (5).
The global burden of asthma is considerable. Surveys, conducted in 29 countries 
worldwide, revealed that over 50% of patients experienced asthma symptoms during 
the day and more than 40% had nighttime awakenings due asthma (6). A telephonic 
survey in Western Europe showed that only 5.3 % of all patients met all the criteria for 
asthma control (7). Over one third of children and half of the adults reported daytime 
symptoms at least once a week and about one third of all patients required an unsched-
uled urgent care visit in the past 12 months. Furthermore, 30% and 50% of children and 
adults, respectively, reported limitation of activities such as sports, social activities and 
school or work absence (7). More recently, a questionnaire survey in the Netherlands 
showed similar characteristics with regard to asthma control (8). The validated Asthma 
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Control Questionnaire (ACQ) showed poor asthma control in 54% of patients and well or 
moderately controlled asthma in the remaining 46% (9, 10). The former group had twice 
as much hospitalizations and urgent primary care visits as the latter group (8). 
diagnosis of asthMa
History taking and physical examination are the basis for diagnosing any disease, as 
it is in asthma. A clinical diagnosis of asthma is prompted by symptoms such as recur-
rent wheeze, breathlessness, shortness of breath, cough, and chest tightness. Typically, 
asthma is characterized by variable, intermittent symptoms, which may be exacerbated 
by exercise, viral infection and exposure to irritant or allergen. (1, 11). On physical 
examination, expiratory wheeze and increased expiratory time may indicate airflow 
obstruction, however these physical signs are often not present (12). 
The presence of asthma may be identified correctly by a combination of specific 
symptoms and signs such as wheeze, dyspnoea, allergen induced symptoms and pro-
longed expiration (13). However, often non-specific symptoms such as coughing, chest 
tightness and fatigue occur and may lead to underdiagnosis of the disease due to un-
awareness by physicians. Patient-related factors such as non-attendance and acceptance 
or poor perception of symptoms may be another cause of underdiagnosis (14). On the 
other hand overdiagnosis is described. A minority of patients in primary care is treated 
with asthma medication without proper indication (15), which stresses the need for 
objective testing to enhance diagnostic confidence. Tests on airflow obstruction, vari-
ability or reversibility such as peak flow examinations or spirometry are recommended. 
Spirometry is the preferred test in general practice to establish a diagnosis of asthma 
(16). About two third of the Dutch general practitioners have an own office spirometer 
and are capable to diagnose asthma accurately (17). 
The studies reported in this thesis include patients with a physician diagnosis of asth-
ma. So-called physician-diagnosed asthma is a conglomerate of patients with positive 
spirometric tests and patients with empirically and successfully prescribed medication, 
who are presumed to have asthma and treated as such. This pragmatic approach reflects 
the heterogeneity of a primary care population and enhances the generalisibility of the 
studies presented.  
asthMa self-ManageMent
The goal of asthma management is to minimize asthma symptoms and short-acting 
bronchodilator therapy, to prevent exacerbations and to achieve and maintain optimal 
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lung function. These goals are to be reached at the lowest possible dose of inhaled cor-
ticosteroids in order to minimize the risk of side effects and optimize user friendliness of 
therapy. Important components of asthma self-management are 1) the assessment and 
monitoring of asthma control, 2) education for a partnership in asthma care, 3) the use 
of an asthma action plan, including pharmacological treatment, and 4) regular medical 
review (18, 19). 
In a Cochrane review of 36 randomised controlled trials, self-management pro-
grams that included all these four components were considered optimal. Optimal 
self-management showed reductions in unscheduled health care visits and nocturnal 
symptoms, but only small changes in lung function. A few studies evaluated the effect 
of optimal self-management on asthma related quality of life. Some found significant 
improvements in quality of life measured with the Asthma Quality of Life Questionnaire 
or St George Respiratory Questionnaire (20, 21), however, others reported only minor 
improvements in asthma related quality of life assessed by these scales (22, 23).
Despite substantial evidence of the beneficial effects of self-management plans in 
asthma, implementation of these plans is poor (24, 25). Patients, as well as health care 
providers, may be reluctant to use asthma action plans, viewing them as time consum-
ing, impractical and complex (26). Time and distance from a medical centre have been 
shown to be barriers to participate in self-management education (27) and significant 
start-up costs may impair the implementation of education programs in daily practice 
(28). 
Internet-based self-management might overcome these barriers. Internet is widely 
available and on-line communication with health care providers is possible asynchro-
nously (i.e. patient and health care provider need not be present at the same time) 
without travel time. Moreover, internet has the possibility of incorporating complex 
treatment algorithms or action plans which may be presented clearly and may be easy 
to use and incorporate into daily clinical practice. 
Asthma self-management and the internet
Three studies have evaluated the effects of asthma management using internet technol-
ogy (29, 30, 31). Rasmussen et al. conducted a 6-month randomised controlled trial in 
300 adults with asthma. Patients in the internet group daily reported symptoms and 
peak flow on an internet diary. An on-line decision support system advised the physi-
cian to increase, decrease or continue the usual treatment. The investigators reported 
improved asthma related quality of life, asthma symptoms and lung function after 6 
months for the internet-based physician-managed care group compared to specialist or 
general practitioner care (30). 
Two studies evaluated the effect of internet-based self-management in children with 
asthma (29, 31). In a 3-month randomised controlled trial comparing an internet-based 
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interactive telemonitoring system with a written asthma diary and self-management 
instructions in children aged 6-12 years, beneficial effects on asthma related quality of 
life, symptoms and peak flow were found (29). However, the only long term randomised 
controlled trial conducted in children aged 6 to 17 years, revealed similar outcomes 
in the internet group and conventional diary group for asthma related quality of life, 
asthma control and lung function after 1 year (31). Therefore, the evidence has shown to 
be inconclusive and incomplete. Internet-based self-management programs so far have 
not included all cardinal components of optimal self-management. 
The development and evaluation of an internet-based self-management support 
program, including self-monitoring, education, an asthma action plan, and medical re-
view is the topic of this thesis. The next four sections describe each component in detail; 




Monitoring of asthma requires understanding of the concepts of asthma severity and 
asthma control. Asthma severity refers to the intrinsic intensity of the disease process. 
The assessment of severity takes into account not only the current symptoms and lung 
function, but also the level of treatment that is required to achieve treatment goals (32, 
33). Severe asthma is defined as the requirement for (not necessarily just the prescrip-
tion or use of ) high-intensity treatment.
Asthma control refers to the degree to which manifestations of asthma are minimized 
and the goals for therapy are met. Two domains of asthma control can be distinguished: 
current impairment and future risk. Current impairment refers to the level of asthma 
symptoms such as wheeze, cough, breathlessness, chest tightness and functional limita-
tions. Future risk includes the risk for exacerbations, progressive lung function decline or 
adverse effects from medication (18, 32). 
The emphasis for asthma management is on asthma control, not on severity. The 
level of asthma control guides decisions to maintain or adjust therapy in order to 
minimize the clinical manifestations of asthma (both impairment and risk) at the lowest 
possible level of medication. Several measures are available for assessing (components 
of ) asthma control: lung function monitoring, symptom monitoring or self-assessment 
questionnaires which include several elements of asthma control such as symptoms, 
activity limitations, need for quick relief medication and/or lung function (9, 34, 35).
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Lung function monitoring
Monitoring of peak expiratory flow (PEF) or forced expiratory volume in the first second 
(FEV1) potentially provides valuable information on asthma control, future risk of asthma 
episodes and for evaluation of the effectiveness of therapy (36, 37). López-Vina et al. 
showed that PEF monitoring increased adherence to prescribed treatment compared to 
symptoms only as a guide to self-management (38). However, effects of PEF monitoring 
on clinical outcomes have proved to be inconsistent; a meta-analysis of peak-flow versus 
symptom based asthma plans showed no differences in hospitalizations, ER visits, days 
lost from school or work, FEV1 and only a slight beneficial effect of peak-flow based plans 
on unscheduled doctor visits and oral corticosteroid courses (39). Moreover, knowledge 
of peak flow did not improve quality of life and symptom scores in a randomised 
controlled trial exploring the effect of PEF recordings in addition to symptom-based 
self-management (40).
The use of conventional, written diaries for lung function reporting is impaired by 
poor adherence and reliability (data falsification). Studies suggest that over 20% of 
reported written lung function recordings are not actually measured, and therefore 
self-invented (41, 42). The number of incorrectly reported written lung function data 
is also considerable, leaving only about 50% of all recordings being correctly reported 
(41). These unsatisfying reports call for novel ways to monitor and report lung function 
in asthma self-management plans in order to guide treatment appropriately. 
Technical innovation has led to the advent of electronic home spirometers. These 
spirometers have shown to provide accurate lung function data, which match the 
criteria of standardized spirometry, even in unsupervised settings (43-46). Subsequent 
reporting of the data can be established either by direct downloads to a PC or manually 
to an internet website or by mobile phone text messaging. Obviously, direct downloads 
to PC or palmtop of spirometric data have the advantage of less incorrect data and no 
self-invented values (29, 46), but implementation of this feature into self-management 
plans is not available yet. 
We therefore evaluated the compliance and reliability of electronic PEF recordings, 
manually reported on the internet or by mobile phone text messaging.
Symptom monitoring and self-assessment questionnaires
Symptom monitoring needs to be valid, reliable, responsive and, if used as part of 
asthma self-management plans, patients must be sufficiently adherent in order to guide 
treatment. For many years, questionnaires have been used in clinical trials to measure 
symptoms in terms of their intensity, duration and characteristic of an episode and the 
frequency of episodes (47-49). However, until recently, the validity and responsiveness 
of symptom monitoring instruments was poorly studied (47, 50).
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The development of self-assessment questionnaires with properly evaluated 
psychometric aspects to assess asthma symptoms and asthma control has evolved 
rapidly in the past decade. International guidelines recommend the use of validated 
self-assessment measures to assess the extent of asthma control such as the Asthma 
Control Questionnaire (ACQ), the Asthma Control Test (ACT) and the Asthma Therapy As-
sessment Questionnaire (ATAQ) (1, 18). The ACQ and ACT have shown to be responsive 
to changing asthma control (51, 52). The ACT covers frequency and intensity of asthma 
symptoms during the past 4 weeks and includes questions on activity limitation and 
rescue medication (52). Similar to the ACT, the ACQ includes items on frequency and 
intensity of symptoms and questions on activity limitations and rescue medication. 
However, it additionally provides information on the characteristics of asthma symp-
toms (wheeze and shortness of breath) and lung function. The ACQ items relate to 
asthma control in the past week and a minimally important difference was estimated to 
be 0.5 on the 7-point scale (51). These features (symptom and lung function assessment; 
weekly questionnaire; responsiveness to change) provide the possibility to incorporate 
the ACQ into an asthma self-management program. 
Despite the recommendation by international guidelines to use this validated 
measure on asthma control over time in clinical research and patient care, its value as 
a guide to adjust treatment in order to improve asthma control has not been shown 
yet. In our internet-based self-management program, we have therefore incorporated 
ACQ self-monitoring and evaluated the effects of treatment guidance according to an 
algorithm based on weekly, consecutive ACQ assessments.
education for a partnership in asthma care
Effective asthma management requires a partnership between the patient with asthma 
and the professionals that deliver asthma health care. This partnership is aimed at em-
powering the patient to manage his or her asthma with guidance from the health care 
professional. By gaining essential knowledge, skills and confidence, patients should be 
able to minimize impairment due to asthma and to maintain normal activity levels (1, 
18). 
Asthma education may take many forms. Limited patient education only consists 
of the transfer of information about asthma and its causes and treatment. Although 
the need for providing information to asthma patients is undisputed, mere transfer of 
information is insufficient to consistently improve asthma symptoms and lung function 
or to reduce doctor visits and hospitalization (53). Therefore, more complex educa-
tional programs have been developed as an integral part of patient self-care. These 
educational programs have been shown to be successful if they are directed toward 
behavioral change and focus on patient empowerment (e.g. patient self-confidence and 
self-efficacy) beyond patient knowledge (19, 54, 55). Thus, as an additive to improving 
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asthma knowledge, the content of educational programs should comprise skills training 
(lung function measurements and inhalation technique), pharmacological and non-
pharmacological treatment instructions, and self-management education with regard 
to the use of an asthma action plan (19, 28, 56). Conversely, provision of an asthma action 
plan without adequate patient education is unlikely to improve patient outcomes (39). 
Some randomized controlled trials have specifically focused on cognitive-behavioral 
change as an outcome of asthma education programs. Cognitive-behavioral outcomes 
such as knowledge, attitudes and self-efficacy with regard to managing asthma are 
improved by self-management education (57-59). Self-management skills such as moni-
toring and adherence to asthma medication, can be influenced positively by tailored 
asthma management programs (57-60).
In our asthma self-management support program we offered education in two ways; 
1) three group-based sessions focusing on patient empowerment to adopt tailored and 
adequate asthma management behavior, and 2) web-based education including all 
core content areas of asthma information. The development of an active partnership 
between patient and health care provider was fostered by on-line web communication. 
The effect of the educational components was assessed and evaluated as part of the 
process evaluation of our program. 
asthma action plans and pharmacological treatment
Step-wise approach
There are two main categories of asthma medications: relievers and controllers. Phar-
macological treatment in asthma is characterized by a step-wise approach (1, 11, 16, 18) 
(figure 1). At each treatment step, reliever medication (usually a short-acting β2-agonist) 
is recommended for quick relief of symptoms. At step 1 this is the only necessary treat-
ment. Patient who present with more frequent symptoms, arbitrarily more than 2 times 
a week, should be provided with controller medication. At step 2 the preferred controller 
medication is a low-dose inhaled corticosteroid. If the treatment goals are not reached 
with step 2 inhaled corticosteroids and appropriate compliance and inhaler device use, 
addition of a long-acting β2-agonist is recommended. Alternative treatment options 
are to increase the dose of inhaled corticosteroids or to add a leukotriene modifier. The 
choice of controller medication to be added in step 4 depends on prior selections at 
steps 2 and 3. The preferred treatment is to combine a medium- or high-dose of inhaled 
corticosteroid with a long-acting β2-agonist (61), but alternative or multiple add-on 
treatment possibilities may be considered. If treatment goals continue to fail with step 
4 therapy oral glucocorticosteroids added to other controller medications may be ef-
fective (62). This option should only be considered after referral to or consultation of a 
chest physician (16).
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figure 1. Stepwise asthma management approach - adapted from GINA guidelines, figure 4.3-2 (1) -
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The step-wise pharmacological approach to gain and maintain asthma control in pa-
tients with persistent symptoms should be distinguished from acute treatment changes 
in patients during an asthma exacerbation. The former (step-wise approach to gain 
and maintain control) provide an ideal strategy against the variable and intermittent 
course of asthma symptoms. The latter (acute treatment changes during an exacerba-
tion) requires immediate consultation (not necessarily face-to-face) of a health care 
provider. Asthma exacerbations are clinically characterized by episodes of increased 
symptoms such as shortness of breath, wheezing, cough or chest tightness and may be 
defined on the basis of symptoms or rapid lung function decline (63, 64). They require 
the administration of rapid-acting inhaled β2-agonist and early administration of oral 
glucocorticosteroids to reduce the number of hospitalizations (65). 
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Treatment instruction in asthma action plans
Personal asthma action plans help individuals with asthma to make changes to their 
pharmacological treatment in response to worsening symptoms or lung function and to 
contact a health care provider in case of emergencies. When incorporated in a complete 
asthma self-management program, which additionally includes monitoring, asthma edu-
cation and regular medical review, asthma action plans have shown to reduce hospital 
admissions and asthma symptoms (19). The way action thresholds are determined vary 
and the various approaches differ in their results. If treatment instructions are given based 
on fall in personal best peak flow, also beneficial effects on mean peak flow were seen, in 
contrast to treatment instructions based on fall in percentage of predicted peak flow (66). 
Symptom-based action plans produce equivalent results compared to peak flow based 
action plans (66). Action plans based on FEV1 measurements have not been studied yet, 
which is not surprising, since home spirometry has only become available recently (43).
Asthma action plans not only need to specify when, but also how to increase treat-
ment and for how long (66). Almost all evaluated action plans recommend a doubling 
of the dose of inhaled corticosteroids in case of deteriorating peak flow or symptoms 
(20, 22, 23, 58, 67-71). Many of these studies report reduced exacerbations (20, 67, 70), 
reduced asthma symptoms (22, 23, 70), improved quality of life (20, 23, 58) or improved 
lung function (22, 69, 70). Remarkably, a study on doubling the dose of inhaled cortico-
steroid as a sole intervention revealed no effect on the number of exacerbations, and 
peak flow or symptom scores (72), suggesting that other factors than only this doubling 
contribute to the observed beneficial results in asthma action plan studies. 
Almost all asthma action plans focus on instructions to increase treatment, but do 
not provide instructions when and how to decrease medication. There is, however, some 
experimental evidence that reducing the dose of inhaled corticosteroid is safe without 
comprising asthma control in patients with stable asthma (73, 74). Guidelines recom-
mend that a 50% reduction in inhaled corticosteroid dose should be attempted at 3 
month intervals (1, 11, 16, 18). The interval of 3 months, however, is arbitrary; the asthma 
action plan in the study of Thoonen e.a. advised the inhaled corticosteroid to be halved 
when peak flow was more than 80% for a period of 6 weeks (23). Although the effects 
of this specific advice were not analysed in detail, the study overall showed that the 
self-management program lowered the perceived burden of asthma and was as least as 
effective as usually provided care (23).
In our self-management support program patients were provided an action plan 
based on the well validated Asthma Control Questionnaire (ACQ). We therefore aimed 
at detecting and managing uncontrolled asthma, rather than at preventing asthma ex-
acerbations. Advices on when, how and for how long to adjust (i.e. increase or decrease) 
treatment were given according to an ACQ based algorithm based on (inter)national 
asthma management guidelines. 
18 Chapter 1 
Medical review
The accuracy of asthma self-management behavior has been shown to decline over 
time (18, 75). Therefore, medical follow-up and review is recommended to take place at 
regular intervals, in order to keep self-management at the required level. In case asthma 
is insufficiently controlled, medical review should be scheduled at 2 to 6 week intervals. 
When asthma is controlled follow-up visits are recommended once or twice each year 
(16, 18). At each visit asthma control, medication technique, use and understanding of 
the asthma action plan and patient adherence should be assessed.
Our self-management program included regular follow-up visits according to the 
national guideline on asthma management (16). Additionally, medical review was avail-
able by on-line communication with our asthma nurse specialist. 
cost-effectiVeness of asthMa self-ManageMent
Since health care resources are scarce it is important to evaluate not only the clinical 
effectiveness of new disease management programs, but also the cost-effectiveness. 
The benefits of a new self-management program should be evaluated against the costs 
in order to justify its implementation. 
The direct costs of asthma, defined as resources consumed, include drugs and de-
vices, consultations with physicians and other health care professionals and hospital 
costs (76, 77). Drug costs make up over 50% of the total direct costs of asthma (77). Non-
medical direct costs consist of time and travel costs (78). The indirect costs of asthma, 
defined as resources that are lost, consist of loss of productive work as a result of the ill 
health of the patient and premature retirement or death (76). 
It has been estimated that approximately three quarters of the total asthma-related 
costs are a result of inadequately controlled disease (76). New asthma self-management 
strategies that aim for good asthma control may therefore reduce asthma costs related 
to uncontrolled disease. However the implementation of the self-management program 
itself will be accompanied by additional, or incremental, costs, which need to be related 
to expected benefits of the program.
A recent systematic review on the cost-effectiveness of peak-flow based asthma 
self-management programs identified 21 studies of which 18 self-management inter-
ventions led to net savings compared with usual care (79). Moreover, 14 out of 17 full 
economic evaluations reported that the new self-management strategy was dominant, 
i.e. more effective and less costly compared with usual care (79). The methodological 
quality, types of costs and different outcomes, however, made it difficult to compare the 
studies and to draw definite conclusions regarding the cost-effectiveness of peak-flow 
based self-management programs.
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To compare the cost-effectiveness of different programs across different diseases it 
is recommended to use a generic measure of outcome, such as quality-adjusted life-
years (QALYs) gained (80). Only one study evaluated the cost-effectiveness of an asthma 
self-management program in terms of QALYs gained (81). Schermer et al. reported an 
average effect of 0.015 QALYs gained per patient and incremental costs per QALY gained 
of  €13,267. At a willingness-to-pay level of €22,500 to gain one additional QALY, the 
probability that self-management was cost-effective compared with usual care was 
52%. In this thesis, we report the results of our cost-effectiveness analysis evaluating the 
costs and QALYs gained by internet-based self-management compared with usual care.
aiMs of the studies
The studies in this thesis explore the potential role of internet-based self-management 
support in the management of asthma and are presented in five chapters. The content 
of these chapters is summarized below.
CHAPTER 2. Peak-flow recordings potentially provide valuable information on risk 
prediction of asthma episodes and effectiveness of treatment, but the use of conven-
tional, written peak-flow diary cards is impaired by poor compliance and reliability. In 
this study, 97 adolescents with asthma were provided with electronic spirometers and 
reported daily peak-flow recordings by using internet or SMS (short message service). 
We examined compliance and reliability of electronic peak-flow recordings for a period 
of four weeks.
CHAPTER 3. Written self-management plans are poorly disseminated and used in primary 
care patients with asthma. In a focus group study following the four week lung function 
monitoring study of chapter 2 we explored 1) the intrinsic barriers to current asthma 
management and 2) the barriers and benefits of internet-based asthma management 
perceived by adolescents with asthma. 
CHAPTER 4. This chapter reports the design and results of a randomised, controlled trial, 
comparing internet-based self-management with usual physician provided care for 200 
adults with asthma, who were followed for one year. Outcomes of the study were related 
to the self-management process and to its clinical effects. 
The process evaluation compared internet-based self-management with usual care 
with regard to educational outcomes (asthma related knowledge, inhaler technique and 
medication adherence), the number of health care provider contacts and medication 
changes. 
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With regard to the clinical effectiveness we evaluated whether internet-based self-
management led to improvements in asthma related quality of life, asthma control, 
symptom-free days, lung function and to a reduction in exacerbations compared with 
usual care.
CHAPTER 5. The level of asthma control at baseline of the study presented in chapter 
4 differed between individuals. About 40% had well controlled asthma, 35% partly 
controlled asthma and 25% poorly controlled asthma. In this study we evaluated the 
monitoring adherence, pharmacological treatment and asthma control changes for the 
three groups with different levels of asthma control at baseline.
CHAPTER 6. New disease management strategies, such as internet-based self-manage-
ment in asthma, require not only an evaluation of the clinical effectiveness, but also of 
their cost-effectiveness. The economic evaluation presented in this chapter investigated 
whether the benefits of internet-based asthma self-management in terms of QALYs 
(quality adjusted life years) were attained at reasonable costs.
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Self-management education is the cornerstone of modern asthma care and consists 
of self-monitoring, transfer of information, a written action plan, and regular medical 
review (1). Current international guidelines recommend the use of home monitoring 
of peak expiratory flow (PEF) as a part of self-monitoring (2). PEF recordings potentially 
provide valuable information on risk prediction of asthma episodes and effectiveness 
of treatment (3). However, compliance and reliability of written PEF diaries is poor (4). 
Information and communication technologies (ICT) such as the internet and mobile 
phone short message service (SMS) are potentially powerful tools in the management of 
asthma. The use of these technologies enables adolescents to fit asthma management 
into their daily life activities. We therefore investigated the compliance and reliability of 
daily PEF measurements by adolescents with controlled and uncontrolled asthma symp-
toms using a handheld electronic spirometer and reporting the data via the internet or 
SMS. 
Ninety seven adolescents aged 12–17 years with physician diagnosed asthma and 
regular prescriptions of low or medium dose inhaled corticosteroids for at least 3 months 
in the previous year were recruited from general practices and from the outpatient clinic 
of the department of paediatrics. Patients using systemic steroids, having no access to 
the internet, and those with serious co-morbidities were excluded. Participants and their 
parents gave written informed consent and the study was approved by the medical 
ethics committee of the Leiden University Medical Center, Leiden, the Netherlands. All 
participants received an electronic spirometer (PiKo1; Ferraris, UK) and were trained to 
perform a forced expiratory manoeuvre. They were asked to perform three manoeuvres 
every morning before taking medication and to report PEF values by typing these daily 
on a designated web application or via SMS for 4 weeks. Participants instantly received 
a receipt message with the PEF value expressed as a percentage of their personal best 
value. They were unaware that the spirometer also stored the values in a memory chip. 
The participants completed the Asthma Control Questionnaire (ACQ) weekly (5). Re-
ported compliance was defined as the proportion of reported PEF entries to the number 
of expected entries. Actual compliance was calculated as the proportion of entries in 
the spirometer memory to the number of expected entries. In order to evaluate reli-
ability, the reported PEF values were compared with the spirometer memory: correctly 
reported values were identical to the spirometer memory values on the same day. We 
distinguished between controlled and uncontrolled asthma symptoms on the basis of 
the mean ACQ score over 4 weeks, a score of ≤0.5 indicating controlled asthma and a 
score of >0.5 indicating uncontrolled asthma. Repeated measures analysis of variance 
was used to assess differences between the 4 weeks and between the two ACQ groups. 
Mean (SD) PEF values were 419 (97) l/min and 378 (86) l/min for the controlled and 
uncontrolled groups, respectively (p=0.052). 
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Overall reported compliance was 90.6% and actual compliance was 91.5%. Actual 
compliance significantly decreased between week 1 (97.2%) and week 4 (83.7%; p<0.01, 
ANOVA). Correctly reported PEF values were found on 79.2% of the days; 2.2% of the 
PEF values were self-invented (table 1). There were no differences between ACQ groups. 
table 1. Reliability of PEF values: mean (SD) percentages of correct, incorrect, self-invented, and missing 
values for patients with controlled and uncontrolled asthma symptoms
Week 1 Week 2 Week 3 Week 4
Patients with controlled asthma symptoms (n=25)*
Correct (%) 93.1  (13.1) 89.7  (14.6) 81.1  (25.0) 67.4  (30.2)
Incorrect (%) 4.0  (9.7) 8.0 (13.7) 9.1  (15.4) 16.0  (24.2)
Self-invented (%) 0.0  (0.0) 0.6  (2.9) 2.9  (7.1) 4.6  (9.0)
Missing (%) 2.9  (7.1) 1.7  (6.3) 6.9  (14.9) 12.0  (17.3)
Patients with uncontrolled asthma symptoms (n=72)†
Correct (%) 86.1  (18.4) 82.1  (21.3) 76.8 (24.4) 69.2  (29.1)
Incorrect (%) 7.5  (12.5) 7.9  (13.3) 9.3 (14.2) 10.1  (12.3)
Self-invented (%) 1.2  (5.7) 1.2 (4.0) 2.0 (5.5) 4.0  (11.3)
Missing (%) 5.2  (11.3) 8.7  (15.5) 11.9 (20.9) 16.7  (26.5)
*Mean (SD) Asthma Control Questionnaire (ACQ) score 0.28 (0.15).
† Mean (SD) Asthma Control Questionnaire (ACQ) score 1.17 (0.56).
Correct, reported PEF values that were identical to memory values on the same day as % of expected 
entries; incorrect, reported PEF values that differed from memory values on the same day; self-invented, 
reported PEF values without a memory value on the same day; missing, expected entries where there was 
no PEF value reported.
We conclude that the compliance and reliability of home PEF measurements by ado-
lescents using the internet or SMS is high over a 4 week period. Actual compliance was 
over 83% during the whole period. Compared with conventional written diary cards, 
electronic monitoring and reporting seems to result in better compliance and reliability 
(4). The internet and SMS are both well established communication tools in the daily 
lives of adolescents, and this probably accounts for these remarkably good results. We 
observed a modest decline in compliance and an increase in erroneous reports over 
time which had not reached a plateau by week 4. The feasibility of long term ICT based 
monitoring by adolescents is therefore uncertain. In our observational study lung func-
tion monitoring was not followed by feedback and/or therapeutic consequences which 
might have negatively influenced compliance over time. Implementation of electronic 
monitoring into an asthma management programme in adults has shown continuing 
high compliance rates (6). This study supports the implementation and evaluation of 
electronic PEF monitoring as part of ICT based asthma management programmes in 
adolescents.
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abstract
background
Internet and short message service are emerging tools in chronic disease management 
of adolescents, but few data exist on barriers and benefits of internet-based asthma 
self-management. Our objective was to reveal the barriers and benefits by adolescents 
with well controlled and poorly controlled asthma to current and internet-based asthma 
management.
Methods
Ninety-seven adolescents with mild to moderate persistent asthma monitored asthma 
control on a designated website. After 4 weeks, 35 adolescents participated in eight 
focus groups. Participants were stratified in terms of age, gender, and asthma control 
level. We used qualitative and quantitative methods to analyze the written focus group 
transcripts.
results
Limited self-efficacy to control asthma was a significant barrier to current asthma man-
agement in adolescents with poor asthma control (65%) compared to adolescents with 
good asthma control (17%) (p < 0.01). The former group revealed the following several 
benefits from internet-based asthma self-management: feasible electronic monitoring, 
easily accessible information, email communication and use of an electronic action plan. 
Personal benefits included the ability to react to change and to optimize asthma control. 
Patients with poor asthma control were able and ready to incorporate internet-based 
asthma self-management for a long period of time (65%), whereas patients with good 
control were not (11%) (p < 0.01). 
conclusions
Our findings reveal a need for the support of self-management in adolescents with 
poorly controlled asthma that can be met by the application of novel information and 
communication technologies. Internet-based self-management should therefore target 
adolescents with poor asthma control.
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introduction
Asthma is the most common chronic disease among adolescents. Its prevalence in this 
age group is about 11% worldwide (1). Despite the availability of potent medical treat-
ment, there is a significant burden of asthma in children and teenagers (2, 3). 
Guided self-management strategies including self-monitoring, continuous educa-
tion, regular medical review, and a written action plan have been shown effective in 
clinical trials (4, 5). The recently updated Global Initiative for Asthma guidelines advo-
cate ongoing self-assessment of asthma control as part of a written personal asthma 
action plan (6). However, patients and doctors are not enthusiastic about paper and 
pencil self-management programs and participation rates are low (7, 8). Structural bar-
riers to participate in a self-management program should be overcome and personal 
benefits should be appreciated (8, 9). Lemaigre et al. have demonstrated the importance 
of external barriers such as time and distance from a medical center to predict the inten-
tion to participate in self-management programs (9). The role of intrinsic barriers such as 
attitude and perceived ability to manage asthma is unknown. 
Internet and short message service (SMS) are potentially powerful tools through which 
guided self-management programs can be delivered to adolescents with chronic disease 
(10-14). To date, it is unknown whether internet and SMS can help to overcome intrinsic 
barriers and can reveal personal benefits of asthma self-management in adolescents. Since 
asthma control predicts acute health care utilization (15), the level of asthma control might 
identify those patients who benefit most from a self-management intervention program. 
We conducted focus group interviews with adolescents with asthma. Our aim was 1) 
to reveal intrinsic barriers to current asthma management and 2) to explore the barriers 
and benefits of internet-based self-management in patients with good and poor asthma 
control, stratified by gender and age. 
Methods and Materials
subjects
Prior to the focus group sessions, we invited adolescents with asthma to participate 
in a one-month observational study on internet-based lung function and symptom 
monitoring. Participants were recruited from 19 general practices (44 general practi-
tioners) in and around Leiden, The Netherlands, and from the outpatient clinic of the 
department of pediatrics of the Leiden University Medical Center. Inclusion criteria were 
physician-diagnosed asthma, age 12-17 years, use of inhaled corticosteroids at least 
three months in the previous year, no serious co-morbid conditions that interfered with 
asthma treatment, access to internet at home and able to understand Dutch. The study 
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was approved by the medical ethics committee of the Leiden University Medical Center. 
All participants gave written informed consent.
design
Ninety-seven adolescents consented to participate in the observational internet-based 
monitoring study (figure 1). All participants received a hand-held electronic spirometer 
(PiKo1; Ferraris, UK) and were trained to perform three maneuvers every morning before 
taking medication and to report FEV1 (lung volume in the first second of a forced expira-








































ACQ: Asthma Control Questionnaire
ATAQ: Asthma Therapy Assessment Questionnaire
a ACQ maximum score<1.0 and ATAQ control score=0
b ACQ maximum score≥1.0 and ATAQ control score≥1
c numbers per age group and gender (M=male, F=female)
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tion) and PEF (peak expiratory flow) values by typing these daily on a designated web ap-
plication or via SMS during a one-month period. Participants instantly received a return 
message with the FEV1 and PEF values expressed as a percentage of expected or personal 
best value, respectively. These electronic return messages were not accompanied by any 
interpretation or treatment advice. The methods have been described previously (13). 
Weekly, the participants completed the Asthma Control Questionnaire (ACQ) via the 
internet. The Asthma Therapy Assessment Questionnaire (ATAQ) was filled in once. 
In March and April 2005, following the electronic monitoring study, we conducted 
eight focus group sessions lasting 1 to 1.5 hour. The goal was to recruit four to eight par-
ticipants per focus group. We stratified the focus groups on the basis of asthma control, 
gender and age (figure 1).
Questionnaires 
Asthma control was measured through the ACQ and the control domain of the ATAQ 
(16, 17). The ACQ contains six questions on asthma symptoms and includes one lung 
function measurement (FEV1). Scores range from 0 (well controlled asthma) to 6. The 
control domain of the ATAQ for adolescents contains seven items; sum scores range 
from 0 (no control problems) to 7. Participants with well controlled asthma were identi-
fied by low scores on both the ACQ (maximum ACQ score during one month <1.0) and 
the ATAQ (control score = 0). Participants with poorly controlled asthma were identified 
by a maximum ACQ score of >1.0 and an ATAQ control score of ≥1 or higher (18-20). 
Attitude and self-efficacy were measured using the Knowledge, Attitude and Self-Effica-
cy Asthma Questionnaire (KASE-AQ) (21).  Mean scores range from 1 to 5 with higher scores 
indicating a more positive attitude and higher self-efficacy toward asthma management. 
focus groups
We used the focus group procedures of Morgan and colleagues in preparing and 
conducting the sessions (22). One moderator and one observer guided the interviews 
according to a carefully constructed protocol (table 1). 
With regard to our first objective (adolescents’ intrinsic barriers to current asthma 
management) we used the Theory of Planned Behaviour as a theoretical framework (23, 
24). It assumes that attitude, perceived social norm and self-efficacy (i.e., perceived abil-
ity) expectations determine a person’s intention to perform a specific behaviour, in our 
case asthma management behaviour.
In order to explore adolescents’ views on barriers and benefits of internet-based 
self-management we addressed the four major elements of asthma self-management 
in the focus group discussions. These elements are self-monitoring of lung function and 
symptoms, transfer of information about asthma, regular medical review and the use of 
an individualized action plan (7). 
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statistical analysis 
All focus group sessions were audio-taped and transcribed in full for analysis. We 
analyzed the transcripts using methods of theory-based and data-based analysis style. 
In theory based analysis the text is organized according to pre-existing theoretical 
categories. In data-based analysis units in the text are identified to form data devel-
oped categories (25). We coded the transcribed text into categories using a software 
program for qualitative data analysis (Nvivo version 1.3; QSR International, Doncaster, 
Australia). The first two transcriptions were independently coded by two researchers 
(HvS and VvdM). Disagreements were solved after discussion. One author (HvS) coded 
the remaining transcriptions (25).
We counted the number of participants who made comments fitting a specific cate-
gory. If a participant made many similar comments, these comments were counted only 
once. We present frequencies of categories and comparative statistics (Fisher’s exact 
test) to support our qualitative analysis and to provide insight in the representativeness 
of the statements (26, 27). 
results
Eighty patients were eligible for participating in the focus groups (well controlled 
asthma, 33 patients; poorly controlled asthma, 47 patients). On the basis of asthma 
control, age and gender 56 adolescents with asthma were invited to participate and 
table 1. Focus group protocol
Intrinsic barriers regarding self-management
1. How do you perceive your asthma? Probes: When do you feel your asthma is under control? How do you 
know your asthma is/is not under control? self-efficacy
2. Do you mind if your asthma is not under control? Probes: Why do / don’t you mind? attitude 
3. What is easy about controlling your asthma? What is difficult about controlling your asthma? Probes: What 
about medication? What about triggers? What about friends, family, doctors? self-efficacy / social norm
4. How do you appreciate asthma management? Probe: Do you take it positively / negatively? attitude
Explanation about monitoring / information / regular medical review / action plan. 
5. How do you appreciate (electronic) monitoring? Probe: How would you feel about monitoring your lung 
function / symptoms daily?
6. How do you evaluate obtaining information (via the internet / via leaflets or books)? Probe: In which way 
would you like to obtain information?
7. How do you appraise visiting a medical practitioner or asthma nurse? Probe: Why is it (not) necessary for 
you to visit your general practitioner / specialist / nurse?
8. How do you value an (internet-based) action plan? Probe: How confident are you to develop your own 
action plan with your doctor / nurse?
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35 (62.5%) attended the focus group sessions. Sessions lasted on average 71 minutes 
(range, 40 to 100 minutes). 
Patient characteristics are listed in table 2. Participants with poorly controlled asthma 
had significantly lower self-efficacy scores on the KASE-AQ self-efficacy subscale than 
participants with well controlled asthma. Attitude towards asthma did not differ be-
tween the groups (table 2). 








Age; years (SD) 14.2 (1.7) 14.7 (1.5) 0.36 e 
Sex; M/F 10/8 7/10 0.51 f
Duration of asthma; years (SD) 7.4 (4.9) 8.8 (5.1) 0.41 e
Current prescription inhaled 
corticosteroids; no. (%) 17 (94.4%) 17 (100%) 1.00 f
Care provider
 primary care; no. (%)






ACQ score (SD) a 0.6  (0.3) 1.9 (0.5) <0.01 e
ATAQ control score (SD) b 0 (0) 2 (1.8) <0.01 e
KASE-AQ: attitude (SD) c 3.7 g 3.8 0.55 e
KASE-AQ: self-efficacy (SD) d 4.0 g 3.6 0.046 e
Pre-bronchodilator FEV1 (% 
predicted); mean (SD) 100.7 (20.9) 90.7 (17.7) 0.14 e
Electronic characteristics
Internet connection
 broadband; no. (%)






Owns mobile phone; no. (%) 17 (94.4%) 14 (82.4%) 0.34 f
Lung function reports 
 by website only
 by SMS only








a   Asthma Control Questionnaire ranges from 0 (optimal asthma control) to 6.The mean of all maximum 
ACQ scores was calculated.
b  Asthma Therapy Assessment Questionnaire; control domain ranges from 0 (optimal control) to 7.
c   Knowledge, Attitude and Self-efficacy Asthma Questionnaire; attitude subscale ranges from 1 
(negative attitude toward asthma) to 5 (positive attitude toward asthma).
d   Knowledge, Attitude and Self-efficacy Asthma Questionnaire; self-efficacy subscale ranges from 1 
(poor perceived ability to control asthma) to 5 (well perceived ability to control asthma).
e  Unpaired t tests.
f  Fisher’s exact test.
g  One missing observation.
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intrinsic barriers to current asthMa ManageMent
Attitude toward asthma management: Participants experienced symptoms as annoying; 
however, nobody perceived asthma as a serious disease. A minority expressed a nega-
tive attitude toward current asthma management. Two participants with well controlled 
asthma expressed attitudes of laziness and unwillingness to take medications; three par-
ticipants with poor asthma control were bothered by the face-to-face medical reviews, 
since they learnt to live with their symptoms and saw no need for regular consultations 
(table 3, panel 1).
table 3. Frequency of categories of statements in the focus group sessions and comparative statistics 










Panel 1: Intrinsic barriers to current asthma management
Negative attitude toward asthma management 2 (11%) 3 (18%) 0.66
Negative social influences 0 (0%) 3 (18%) 0.11
Limited perceived ability to manage asthma 3 (17%) 11 (65%) < 0.01
Panel 2: Barriers and benefits of internet-based self-management b
2.1 Internet-based monitoring
 Electronic monitoring is feasible 15 (83%) 15 (88%) 1.00
 Recognize benefits of electronic monitoring 1 (6%) 4 (24%) 0.18
2.2 Internet information
 Need for comprehensive information 3 (17%) 5 (29%) 0.44
 Positive features of internet information 11 (61%) 12 (71%) 0.73
2.3 Internet-based medical review
 Positive attitude toward electronic consultation 8 (44%) 10 (59%) 0.51
 Negative attitude toward electronic consultation 2 (11%) 2 (12%) 1.00
2.4 Internet-based action plan
 Able and ready to use internet-based action plan 2 (11%) 11 (65%) < 0.01
 No need to use action plan at all 14 (78%) 3 (18%) < 0.01
a  Fisher’s exact test.
b  Four components of asthma self-management programs (Gibson et al. Respir Med 2003).
Social norm: Only three participants with poorly controlled asthma reported negative 
social influences during sports and social activities (table 3, panel 1). They experienced 
social rejection by teachers or peers at school, who took no account of the patient’s 
asthmatic symptoms. 
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Self-efficacy to manage asthma: About two-third of the participants with poor asthma 
control expressed limited perceived ability to control asthma (table 3, panel 1). There 
were situations in which they felt helpless with regard to gaining asthma control. They 
thought nothing could be done about symptoms or about an attack. Patients said they 
experienced symptoms or an attack even after administering medication. The majority 
of these participants experienced symptoms, but said that they were used to symptoms 
as a part of everyday life and that they had learnt to live with them (table 4). 
table 4. Expressions of acceptance of asthma symptoms
‘It’s just something you’ve got. Medications do help, but you just have these symptoms. So I think it’s 
something that is just a part of it.’
‘You accept it and learn to live with it. I’ve got it since I was a kid, so I don’t know any better.’ 
‘I don’t think when I’m short of breath: oh dear, I’ve asthma, how bad! Some have a bloody nose, others have 
asthma. I’ve had it for such a long time, so I get used to it.’
‘There are others with more serious problems. Then I think…I’ve just got asthma and if it stays like this, I’m 
satisfied.’
Views on barriers and benefits of internet-based asthma self-management
Monitoring: The majority of participants held the view that internet-based monitoring 
and reporting was feasible (table 3, panel 2.1). They mentioned that it was not time 
consuming and did not interfere with their daily activities. Sending lung function values 
and symptom scores via the internet or SMS was easy and fast. 
Patients in the well controlled group had fun doing the measurements, but did not 
think it was very useful. They felt able to personally register deteriorating symptoms 
without using electronic lung function measurements or symptom scores. They did 
not observe benefits from daily electronic monitoring and feedback, since they did not 
experience any symptoms at the moment.
About a quarter of patients with poor asthma control did report the usefulness of 
measuring their lung function daily and getting instant feedback (table 3, panel 2.1). 
Observing symptoms and lung function over time and being able to react to changes 
in asthma were mentioned as personal benefits of internet-based monitoring, reporting 
and feedback. Almost nobody with poorly controlled asthma worried about monitoring 
for a long time (ie, > 1 year).
Information: In general, participants noted that they had not obtained much information 
on asthma or asthma medication in the past. Some said they had got some information 
many years ago, but could not remember which information or only remembered that 
they did not understand. 
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A quarter of all participants expressed a need for information about asthma. Par-
ticipants wanted to obtain information about the cause of asthma, functioning of the 
lungs and mechanisms of asthma medication. We did not observe differences between 
participants with good and poor asthma control (table 3, panel 2.2).
The majority of participants did not express a need for extra information about 
asthma. They believed they had sufficient knowledge regarding how and when to use 
controller and reliever puffs. Some participants with well controlled asthma thought 
it would be useful to provide information about asthma to patients with more severe 
symptoms, but not to themselves. All patients agreed that if information was offered it 
should be offered through the internet and not through, for instance, leaflets or books 
from the asthma foundation. Internet is easy to use, easily accessible (‘I have a computer 
with internet connection in my bedroom’) and provides the opportunity to show graph-
ics and short films. Most participants felt that just plain text was rather boring.
Regular medical review: Most participants thought it was not necessary to visit their 
physician if their asthma was under control. Three patients even mentioned that doctor 
visits were annoying. During doctor visits, lung values were measured, and if these were 
acceptable, you could leave. Patients preferred to visit their doctor only when symptoms 
were getting worse. 
Participants were enthusiastic about the internet-based review by sending lung 
values and symptom scores via the internet or SMS, with the possibility to add com-
ments or questions (table 3, panel 2.3). Patients with poorly and well controlled asthma 
mentioned that e-mail communication and electronic consultation was useful (table 5). 
Almost everyone used the computer daily. Most participants felt no need to see their 
physician or nurse in person for regular review. 
table 5. Participants’ views on electronic communication
Participant with well controlled asthma :
‘I don’t need to see a doctor or nurse personally. If I know she [doctor or nurse] sees my values, then it’s okay for 
me. Maybe when things go worse, I’d like to be examined, but if things go just normally, I don’t mind to be in 
contact just by email.’
Participant with poorly controlled asthma:
‘I don’t need personal contact. One should just trust the advice. It’s about the advice not about the nurse or 
doctor. So I think electronic consultation is rather useful.’
Individualized action plan: Almost 80% of the patients with well controlled asthma saw 
no need for an individualized written action plan (table 3, panel 2.4). They mentioned 
that they did not need it, that they already managed their asthma themselves and that 
it was unpleasant or difficult to develop a personalized action plan with a health-care 
professional on how to adjust treatment in response to worsening asthma control. Some 
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said that it may be useful for others but not for themselves. Only two participants were 
willing to use an electronic action plan, which involved daily monitoring, for a long 
period of time.
In contrast, two third of participants with poor asthma control mentioned that it was 
useful to formulate an action plan on the internet (table 3, panel 2.4). They appreci-
ated messages when lung function or symptoms deteriorated and they valued advice 
on how and when to change asthma medication. Participants with poorly controlled 
asthma were able and ready to use an internet-based asthma self-management plan for 
a long period of time (ie, at least a year). 
discussion
We conducted focus group interviews with adolescent asthma patients to reveal the 
intrinsic barriers in current asthma management and to explore barriers and benefits of 
internet-based asthma self-management. A limited perceived ability to control asthma 
was the most striking barrier to current asthma self-management in adolescents with 
poor asthma control. Patients indicated their inability to adequately manage symptoms 
and, therefore, accepted symptoms to a large extent. This particular group clearly 
expressed several benefits from internet-based asthma self-management: electronic 
monitoring and feedback, easily accessible information, email communication and an 
electronic action plan. 
Our study protocol was unique in its design. Since we performed an observational 
study on electronic lung function and symptom monitoring prior to the focus groups 
we were able to identify patients with poorly and well controlled asthma and to focus 
on differences between these groups. The most striking difference in intrinsic barriers to 
current asthma management between patients with poorly and well controlled asthma 
was the fact that the former group did currently not feel able to manage asthma and 
accepted asthma symptoms as part of their everyday life. It is, however, well known that 
there is no need to accept asthma symptoms, since good asthma control can be achieved 
in the vast majority of patients (28). In the context of guided asthma self-management 
it is important for patients to become aware of achievable asthma control through 
information and education and to empower patients in self-managing their asthma by 
using feasible management programs.
Another advantage of the study design is that patients participated in electronic 
monitoring via the internet and SMS prior to the focus group sessions, which informed 
their opinions. In contrast to a questionnaire survey and a recent study using discrete 
choice experiments with hypothetical scenarios which raised concerns about workload 
and interference with day to day lives (14, 29), we learnt that electronic monitoring 
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and reporting was no burden at all and easy to incorporate in the daily activities of 
adolescents. Previous studies have doubted the compliance and reliability of home 
monitoring by asthmatic patients when they were also required to keep a conventional 
paper diary (30, 31). However, use of electronic monitoring alone appears to improve 
outcomes of compliance and reliability and may thus provide a useful tool in guided 
self-management (13, 32). 
Some patients expressed a need for information on, for example, the cause of asthma, 
the functioning of the lungs and mechanisms of asthma medication. From the intrinsic 
barriers to manage asthma, mentioned by participants with poorly controlled asthma, 
we learnt that there is room for improvement of self-efficacy activities. Inaccurate beliefs 
about the need to accept asthma symptoms and the cause of asthma can be addressed 
during information or education sessions. Participants indicate that the internet is 
the most convenient way for obtaining information on asthma matters rather than, 
for instance, the leaflets of the asthma foundation. The preference for internet-based 
information over leaflets is likely to relate to the existing practices of this particular age 
group, but would not necessarily be reported by elderly patients. (11)
Adolescents’ views on regular medical review are in concordance with what we 
know from adult interviews (33). Face-to-face consultations are appropriate in those 
with deteriorating asthma but are not accepted for reviewing well controlled asthma. 
Participants did not mind communicating by e-mail or SMS without having face-to-face 
contact with a health care provider.
In accordance with previously published focus group research in which patients did 
not appear to be enthusiastic about guided self-management plans (8), we observed 
that patients with good asthma control are not willing to use self-management plans. 
They did not think these plans are useful for them or they believed that they were al-
ready managing their asthma competently. In contrast, most participants with poorly 
controlled asthma favored the further use of electronic self-management plans. 
A limitation of our study is that we counted only verbal statements made in the focus 
groups. A drawback of this analysis is that non-verbal expressions are not counted (e.g., 
nodding agreement with a statement made by another participant) (25). Nevertheless, 
to our opinion these quantitative counts of verbal utterances support our qualitative 
findings.
A second limitation concerns the selection of patients. Since 63% responded to our 
invitation to join the focus groups, we must be cautious in generalizing our results. We 
may have observed the opinions of a selected group of patients willing to participate in 
asthma self-management programs. On the other hand this assumption does not hold 
in patients with well controlled asthma who were reluctant to use guided self manage-
ment plans. 
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Our findings reveal that there is a need to overcome limited perceived ability in 
current asthma management of adolescents with poor asthma control. Internet-based 
self-management appears to be a powerful tool to overcome limited self-efficacy in this 
group of patients. Adolescents with poorly controlled asthma recognize the extensive 
potential benefits of internet-based self-management and are ready and able to use 
a guided self-management program including internet and short message service 
over a long period of time (ie, at least 1 year). This group can be easily identified by 
administering short questionnaires on asthma control. Adolescents with well controlled 
asthma are unlikely to use internet-based self-management programs. Internet-based 
self-management should therefore target adolescents with poor asthma control.
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CHAPTER 4
Internet-based self-management plus education compared 
with usual care in asthma: a randomized controlled trial
Victor van der Meer, Moira J. Bakker, Wilbert B. van den Hout, Klaus F. Rabe, 
Peter J. Sterk, Job Kievit, Willem J.J. Assendelft, Jacob K. Sont 




The Internet may support patient self-management of chronic conditions, such as 
asthma.
objective 




37 general practices and 1 academic outpatient department in The Netherlands
Patients 
200 adults with asthma who were treated with inhaled corticosteroids for 3 months or 
more during the previous year and had access to the Internet.
Measurements 
Asthma related quality of life at 12 months (minimal clinically significant difference of 
0.5 on the 7-point scale), asthma control, symptom-free days, lung function, and exac-
erbations. 
intervention 
Participants were randomly assigned by using a computer-generated permuted block 
scheme to Internet-based self-management (n=101) or usual care (n=99). The Internet-
based self-management program included weekly asthma control monitoring and 
treatment advice, on-line and group education, and remote Web communications. 
results 
Asthma related quality of life improved by 0.56 and 0.18 points in the Internet and usual 
care groups, respectively (adjusted between-group difference, 0.38 [95% CI, 0.20 to 
0.56]). An improvement of 0.5 point or more occurred in 54% and 27% of Internet and 
usual care patients, respectively (adjusted relative risk, 2.00 [CI 1.38 to 3.04]). Asthma 
control improved more in the Internet group than in the usual care group (adjusted 
difference -0.47 [CI, -0.64 to -0.30]). At 12 months, 63% of Internet patients and 52% 
of usual care patients reported symptom-free days in the previous 2 weeks (adjusted 
absolute difference, 10.9% [CI 0.05% to 21.3%]). Pre-bronchodilator FEV1 changed with 
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0.24 L and -0.01 L for Internet and usual care patients, respectively (adjusted difference, 
0.25 L [CI, 0.03 to 0.46 L]). Exacerbations did not differ between groups. 
limitations 
The study was unblinded and lasted only 12 months.
conclusion 
Internet-based self-management resulted in improvements in asthma control and lung 
function, but did not reduce exacerbations, and improvement in asthma-related quality 
of life was slightly less than clinically significant.
introduction
Asthma is a chronic disorder of the airways that is characterized by recurring respiratory 
symptoms, variable airflow obstruction, airway hyperresponsiveness, and underlying 
inflammation (1, 2). Recent clinical guidelines for the management of asthma distinguish 
four essential components of asthma care: assessment and monitoring, patients’ educa-
tion, control of environmental and co-morbid factors that affect asthma, and drug treat-
ment. With appropriate medical care, well-informed and empowered patients can control 
their asthma and live full active lives (1, 2). However, despite the availability of monitoring 
tools and effective therapy, asthma control is suboptimal in many patients worldwide, 
and long-term management falls far short of the goals set in the guidelines (3).
Self-monitoring, education and specific medical care are important aspects in 
improving the lives of asthma patients (1, 2). However, many patients with mild or 
moderate persistent asthma do not attend check-ups regularly or visit their doctor with 
symptoms of the disease (4). In addition, in practice, both patients and their health care 
providers are reluctant to use written self-management plans (5).
Internet technology is increasingly being seen as an appealing tool to support self-
management for patients with chronic disease in remote and underserved populations 
(6-8). However, to date, studies on Internet-based asthma self-management show only 
short-term improvements in asthma control, lung function and quality of life (9-11). 
Long-term studies on the effect of Internet-based self-management, including all its 
essential features, are not available.
Therefore, we developed a guided self-management tool for adult patients with 
asthma that included Internet-based home monitoring and treatment advice (action 
plan), on-line education and remote Web communication with a specialized asthma 
nurse. The goal of our study was to assess the long-term clinical effectiveness of Internet-




We conducted a 12-month, multicenter, nonblinded, randomized, controlled trial. We 
randomly assigned patients to Internet-based self-management (Internet group) as an 
adjunct to usual care or to usual physician-provided care alone (usual care group). The 
Internet-based self-management program included weekly asthma control monitoring 
and treatment advice, online and group education, and remote Web communications 
with a specialized asthma nurse. The intervention continued for 12 months after enroll-
ment. The Medical Ethics Committee of the Leiden University Medical Center, Leiden, 
the Netherlands, approved the study.
setting and Participants
We recruited patients from 37 general practices (69 general practitioners) in the Leiden 
and The Hague area and the Outpatient Clinic of the Department of Pulmonology at 
the Leiden University Medical Center from September 2005 to September 2006. Inclu-
sion criteria were physician-diagnosed asthma coded according to the International 
Classification of Primary Care in the electronic medical record (12), age 18 to 50 years, 
prescription of inhaled corticosteroids for at least 3 months in the previous year, no seri-
ous co-morbid conditions that interfered with asthma treatment, access to the Internet 
at home, and mastery of the Dutch language. We excluded patients who were receiv-
ing maintenance oral glucocorticosteroid treatment. On the basis of diagnosis, age, 
prescribed asthma medication, and co-morbid conditions, we sent eligible patients an 
invitation letter followed by 1 reminder letter after 2 to 4 weeks if they did not respond 
to the first. We continued this process until a total of 200 patients had entered the study 
(September 2006). All participants gave written consent. 
randomization and intervention
In a 2-week baseline period before randomization, we collected data on patient demo-
graphic characteristics, asthma-related quality of life, symptom control, lung function, 
and medication level. We provided basic education about core information on asthma, 
action of medications, and inhaler technique instructions to all patients. We trained 
all participants to measure FEV1 daily with a hand-held electronic spirometer (PiKo-1, 
Ferraris Respiratory, Hertford, United Kingdom) and to report the highest value of 3 
measurements in the morning before taking medication (2, 13). They were shown how 
to report these values on a personal page on a secure Web application by using a login 
password (or how to report by mobile telephone text message). Patients were also asked 
to report their nighttime and daytime asthma symptom scores on this Internet page 
or by text message. We asked all participants to complete the Asthma Control Ques-
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tionnaire on their personal Internet page each week (14). We did not give any patients 
feedback about lung function or asthma control. 
After the 2-week baseline period, we randomly assigned participants to either the 
Internet group or the usual care group. We stratified according to care provider (pri-
mary vs. subspecialty care) and asthma control at baseline (15). We randomly assigned 
patients to the 2 groups (1:1 ratio) by using a computer-generated, permuted-block 
scheme. Allocation took place by computer after collection of the baseline data, ensur-
ing concealment of allocation.
The Internet-based self-management program consisted of the 4 principal compo-
nents of asthma self-management and was accessed through the specially designed 
Web site, which allowed monitoring through the Web site (or text message on a mobile 
telephone), use of an Internet-based treatment plan, online education, and Web commu-
nications with a specialized asthma nurse (16). Patients monitored their asthma weekly 
by completing an electronic version of the Asthma Control Questionnaire on the Web 
site and instantly received feedback on the current state of their asthma control along 
with advice on how to adjust their treatment according to a predefined algorithm and 
treatment plan (Table 1 and Appendix Figures 1, 2, 3, 4, and 5). Depending on the scores 
submitted, patients received 4 types of self-treatment advice. When 4 consecutive Asthma 
Control Questionnaire scores were 0.5 or less, patients were advised to decrease treat-
ment according to treatment plan. When 2 consecutive scores were greater than 0.5 but 
less than 1.0, patients were advised to increase treatment according to treatment plan. 
When 1 score was 1.0 or more but less than 1.5, patients were advised to immediately 
increase treatment according to treatment plan. Finally, when 1 score was 1.5 or more, 
patients were advised to immediately increase treatment and contact the asthma nurse.
table 1. Treatment plan
Step* Medication
1 As needed rapid-acting β2-agonist†
2 Low-dose inhaled glucocorticosteroids
3a Low-dose inhaled glucocorticosteroids plus long-acting β2-agonist
3b Medium-dose inhaled glucocorticosteroids
3c High-dose inhaled glucocorticosteroids
4a Medium-dose inhaled glucocorticosteroids plus long-acting β2-agonist
4b High-dose inhaled glucocorticosteroids plus long-acting β2-agonist
4c Contact asthma nurse‡ : consider addition of leukotriene modifier
5 Contact asthma nurse‡ : consider addition of oral glucocorticosteroid
*  Step numbers correspond with recommended steps in the Global Initiative for Asthma guidelines (1).
†  Applies to all treatment steps.
‡  Or other health care provider.
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We advised no medication changes during the 4 weeks after treatment was stepped 
up (evaluation period). In addition to weekly assessments, patients could optionally 
report daily symptoms and lung function and were able to contact our asthma nurse 
through the Web or by telephone. Thus, any acute deterioration warranting a visit to the 
general practitioner or hospital could be detected (Appendix Figures 2 and 3).
We aimed to empower patients to use the Internet-based self-management tool and 
to develop a patient–provider partnership in asthma care (2). Self-management educa-
tion consisted of both Web-based and face-to-face, group-based education. Web-based 
education included asthma information, news, frequently asked questions, and interac-
tive communication with a respiratory nurse specialist. We scheduled 2 group-based 
education sessions, which lasted 45 to 60 minutes, for patients in the Internet-based 
self-management group within 6 weeks after entering the trial. Both sessions included 
exploration of a patient’s interests and previous knowledge (negotiating an agenda and 
patient-centered education), personalized feedback, and empowerment of self-man-
agement (self-efficacy and implementing a plan for change) (2, 17). The first educational 
session also included pathophysiology of asthma, information on the Web-based ac-
tion plan, and information and review of inhalation technique. The second educational 
session gave information about the mechanisms and side effects of medication and 
explained trigger avoidance.
Patients in the usual care group received asthma care according to the Dutch general 
practice guidelines on asthma management in adults, which recommend a medical 
review and treatment adjustment every 2 to 4 weeks in unstable asthma and medical 
review once or twice yearly for patients whose asthma is under control (18). These na-
tional guidelines are based on international guidelines, such as the Global Initiative for 
Asthma guidelines (1, 18).
outcomes, Measurements and follow-up Procedures
Process Evaluation
The process evaluation included educational outcomes (asthma knowledge, inhaler 
technique, and self-reported medication adherence), health care provider contacts 
for asthma, use of the Internet-based monitoring tool, and medication changes. We 
assessed asthma knowledge with the 12-item Consumer Asthma Knowledge Question-
naire (19, 20) and inhalation technique with the standardized checklist of the Dutch 
Asthma Foundation (21). We assessed knowledge, inhaler technique, and medication 
adherence at baseline and 12 months. 
Health care provider contacts included physician visits, telephone contacts (quar-
terly questionnaire), and remote Web communications with a specialized asthma nurse. 
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We extracted the frequency of Internet-based monitoring from Web site log files and 
included optional daily lung function and symptom monitoring and weekly Asthma 
Control Questionnaire monitoring. 
Medication use was reported at baseline, 3 months, and 12 months. For each patient, 
we measured the number of medication changes (or steps) by comparing treatment 
step at 3 months with treatment step at baseline (number of medication changes in first 
3 months) and treatment step at 12 months with treatment step at 3 months (number 
of medication changes in the next 9 months). We totaled the numbers of medication 
changes in the first 3 months and next 9 months and reported averages per patient.
Clinical Outcomes
The primary clinical outcome measure was asthma-related quality of life, as measured 
by the 32-item Asthma Quality of Life Questionnaire (22). The minimal important differ-
ence is 0.5 on a 7-point scale. We assessed 5 secondary clinical outcomes: asthma con-
trol (minimal important difference is 0.5 on the 7-point Asthma Control Questionnaire 
scale), symptom-free days, prebronchodilator FEV1, daily inhaled corticosteroid dose, 
and exacerbations. We assessed all outcomes except for exacerbations over 2 weeks, at 
3 months, after the baseline period, and again at 12 months. During these assessments, 
all patients kept Internet-based daily diaries as they had during the baseline period. 
We restricted Web site access for usual care patients to this diary page. We defined 
symptom-free days as a night and day without asthma symptoms or being awakened 
by asthma symptoms, as measured by the TRUST (The Regular Use of Salbutamol Trial) 
diary card (23). We measured prebronchodilator FEV1 during each 2-week assessment 
period (the end value used for analysis). We calculated daily inhaled corticosteroid 
dose as fluticasone equivalents. We defined exacerbations as deterioration in asthma 
that required emergency treatment or hospitalization (collected by quarterly question-
naire) or the need for oral steroids for 3 days or more (collected by pharmacy records), 
as judged by the attending physician, and assessed them over the whole year (24). We 
collected all outcome data similarly in both groups. Participants provided the Asthma 
Control Questionnaires, symptom-free days, and prebronchodilator FEV1 through the 
Internet (the usual care group had limited access to the Web site for 2 weeks at baseline, 
3 months, and 12 months). We collected the other outcomes by written questionnaires.
statistical analysis (including power calculation)
Our primary objective was to determine whether changes in asthma-related quality of 
life (Asthma Quality of Life Questionnaire score) differed between the Internet group 
and the usual care group. With a total of 100 patients per group, an SD of 0.75 (17), and 
a correlation coefficient of 0.5, our repeated-measures analysis had a statistical power 
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of 80% (at the 2-tailed 5% significance level) to detect a 0.26-point difference in Asthma 
Quality of Life Questionnaire score. 
We analyzed the differences in the demographic characteristics between participants 
and non-participants and differences in baseline characteristics between the 2 random-
ization groups by using Fisher exact tests and unpaired Student t tests for proportions 
and continuous data, respectively. We analyzed within- and between-group differences 
in the process outcomes with paired and unpaired Student t tests, respectively. 
We analyzed changes in the Asthma Quality of Life Questionnaire scores, Asthma 
Control Questionnaire scores, percentage of symptom-free days, and lung function by 
using linear mixed-effects models. We added a random intercept at the patient level 
to adjust for repeated measurements over time (25). We added 6 covariates (sex, age, 
education level, smoking status, type of care provider, and number of control problems 
in the previous year) to the models. We entered time to the models as a categorical co-
variate. We aimed the primary analysis at treatment effects after 12 months. In addition, 
we analyzed differences in treatment effects between 3 and 12 months. We compared 
exacerbations between the 2 groups with a Cox proportional hazards model, including 
the same 6 covariates as added to the linear mixed-effects model. 
To estimate the number of patients who gained a clinically important benefit from 
treatment, we used logistic regression analysis with “clinical improvement at 12 months” 
as a dichotomized outcome and the same 6 covariates, as previously described (26). We 
analyzed complete cases and did not impute missing values. Clinical improvements in 
Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores were 
changes from baseline of 0.5 or more and changes from baseline of −0.5 or less, respec-
tively (27, 28). As the outcomes of interest were common, odds ratios were inappropriate 
to estimate relative risks (RRs); therefore, we recalculated them into RRs with CIs on the 
basis of marginal standardization by using a bootstrap method (29). 
We did all analyses on an intention-to-treat basis. We did not impute missing values. 
We used Stata, version 9.0 (StataCorp, College Station, Texas), for all analyses. 
results
We invited the 930 patients who met the selection criteria to participate in the study. Pa-
tients who consented to participate (n = 200 [21.5%]) did not differ from non-participants 
in age (mean age, 36.6 years vs. 35.8 years; P = 0.27) or socioeconomic status (living in an 
underprivileged area, 5.0% vs. 7.1%; P = 0.29), but they did differ in sex (women, 69.5% 
vs. 59.7%; P = 0.012). Baseline characteristics of the randomization groups were similar 
(Table 2).
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table 2. Baseline characteristics
Usual care group (n=99) Internet group (n=101)
Men, % 29% 32%
Mean age (range), y 37 (18-50) 36 (19-50)




























Mean FEV1 (pre-bronchodilator) (range), L 3.13 (1.56-5.23) 3.08 (1.14-5.19)
Mean FEV1 (pre-bronchodilator) (range), % predicted 90 (53-118) 88 (34-133)
Mean daily inhaled corticosteroid dose (range), μg 517 (0-2000) 497 (0-1000)
Inhaled long-acting β2-agonist use, % 60% 59%
Leukotriene modifier use, % 2% 3%
Mean educational outcomes (range) *
 Asthma knowledge †
 Inhaler technique ‡








 Mean Asthma Quality of Life Questionnaire score (range)
 Mean Asthma Control Questionnaire score (range)







Data are mean (range) or percentage unless otherwise indicated. 
FEV1 =  Forced expiratory volume in 1 second. 
* Baseline data for asthma knowledge and self-reported medication adherence were available for 91 
and 99 patients in the usual care and Internet groups, respectively. † Consumer Asthma Knowledge 
Questionnaire score range (worst – best), 0 – 12.  ‡ Checklist of the Dutch Asthma Foundation score range 
(worst – best), 0 – 5. § Range: 0 – 7 d/wk.
Process evaluation
Asthma knowledge improved in the Internet group (0.42 [95% CI, 0.05 to 0.79]) and the 
usual care group (0.86 [CI, 0.35 to 1.36]), but the improvements did not differ between 
the groups (P = 0.70) (Table 3). Similarly, inhalation technique improved in the Internet 
group (0.21 [CI, 0.04 to 0.38]) and the usual care group (0.32 [CI, 0.15 to 0.50]), but the 
improvements did not differ between the groups (P = 0.143) (Table 3). There were no 
within- or between-group differences in self-reported medication adherence.
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Patients in the Internet group had 5.9 (CI, 4.8 to 7.1) online contacts with the asthma 
nurse during the 1-year follow-up. The Internet group had slightly fewer physician visits 
than the usual care group (−0.74 physician visits [CI, −1.55 to 0.06 physician visits]). Pa-
tients in the Internet group reported optional daily lung function and symptom scores 
at 108 days (CI, 98 to 126 days) and Asthma Control Questionnaire scores at 35 weeks 
(CI, 31 to 38 weeks). Treatment increases (step-up) and decreases (step-down) both oc-
curred more often in the Internet group than in the usual care group (Table 3).  





Difference (95% CI) P Value
Educational outcomes
 Asthma knowledge *
 Inhaler technique †







0.11 (-0.44 to 0.66)
0.15 (-0.05 to 0.34)




Health care provider contacts for asthma, average number per patient
 Physician visits
  Telephone contacts with health care 
provider







-0.74 (-1.55 to -0.06)





Use of Internet-based monitoring tool §
  Optional daily lung function scores, average 
days per patient
  Asthma Control Questionnaire monitoring, 









Medication changes, average number per patient
 Step-up in treatment





0.51 (0.30 to 0.72)
0.31 (0.09 to 0.53)
<0.001
0.006
NA = not applicable. * Consumer Asthma Knowledge Questionnaire score range (worst – best), 0 – 12. † 
Checklist of the Dutch Asthma Foundation score range (worst – best), 0 – 5. ‡ Range: 0 – 7 days a week. § 
Obtained from Web site log files available for all patients in the Internet group (n = 101).
clinical outcomes
Participants did not deviate from the study protocol. We obtained 90% and 91.5% of 
primary outcome data during the assessment periods at 3 and 12 months, respectively 
(Figure 1). The analysis set included all randomly assigned patients who provided any 
data during the study. 
Table 4 summarizes the results of the primary and secondary clinical outcomes (table 4). 
Asthma-related quality of life (Asthma Quality of Life Questionnaire) improved more in the 
Internet group than in the usual care group (change from baseline, 0.56 vs. 0.18; adjusted 











































































































































































































































































































































































































































































































































































































































difference, 0.38 [CI, 0.20 to 0.56]) (Figure 2 A). This treatment effect was not statistically dif-
ferent between 3 and 12 months. Patients assigned to the Internet group more often had 
a clinically relevant improvement (≥0.5) in asthma-related quality of life than did those 
in the usual care group (54% vs. 27%; adjusted RR, 2.00 [CI, 1.38 to 3.04]) (Figure 3, top).
The Internet group showed greater improvement of asthma control (Asthma Control 
Questionnaire) than did the usual care group (change from baseline, −0.54 vs. −0.06; 
adjusted difference, −0.47 [CI, −0.64 to −0.30]) (Figure 2 B, and Table 4). This treatment 
effect was not statistically different between 3 and 12 months. Patients assigned to the 
Internet group had a clinically relevant improvement (−0.5 or less) in asthma control 
more often than those in the usual care group (48% vs. 17%; adjusted RR, 2.87 [CI, 1.86 
to 5.14]) (Figure 3, bottom). 
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After 12 months, the proportion of symptom-free days reported for the previous 2 
weeks increased by an absolute 18.2% and 7.3% (adjusted difference, 10.9% [CI, 0.05% 
to 21.3%]) in the Internet and usual care groups, respectively. Prebronchodilator FEV1 
changed by 0.24 L and −0.01 L (adjusted difference, 0.25 L [CI, 0.03 to 0.47 L]) for the 
Internet and usual care groups, respectively (Figure 2 C). Daily inhaled corticosteroid 
dose did not statistically significantly differ after 12 months (difference, 57 μg [CI, −38 
to 152 μg]) (Figure 2 D). However, a statistically significant time-by-intervention effect 
occurred during the first 3 months when the daily inhaled corticosteroid dose increased 
by 164 μg (P < 0.001) in the Internet group followed by a change of −107 μg (CI, −202 to 
−12 μg; P = 0.027) in the next 9 months in the Internet group compared with the usual 
care group. During follow-up, 17 exacerbations occurred in 11 patients in the Internet 
figure 2. Changes in mean Asthma Quality of Life Questionnaire score (A), Asthma Control Questionnaire 
score (B), FEV1 (C), and daily inhaled corticosteroid dose (D) during 1-year follow-up for the Internet group 
















































































































Number of subjects, n
The minimal important difference for the Asthma Quality of Life Questionnaire score is 0.5, with 
higher scores indicating better quality of life. The minimal important difference for the Asthma Control 
Questionnaire is 0.5, with lower scores indicating better asthma control. Plotted values are based on 
complete cases. Error bars indicate 95% CIs. P values are shown for between-group differences in change 
scores at 12 months and are from linear mixed-effects models.
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group compared with 20 exacerbations in 10 patients in the usual care group (hazard 
ratio, 1.18 [CI, 0.51 to 2.74]).















δ≤-1.5 -1.5<δ≤-1.0 -1.0<δ≤-0.5 -0.5<δ<0.5 0.5≤δ<1.0 1.0≤δ<1.5 δ≥1.5
Asthma Control Questionnaire score change after 12 months













δ≤-1.5 -1.5<δ≤-1.0 -1.0<δ≤-0.5 -0.5<δ<0.5 0.5≤δ<1.0 1.0≤δ<1.5 δ≥1.5
Asthma Quality of Life Questionnaire score change after 12 months
Usual Care
Internet-based Self-management
Clinically relevant improvementClinically relevant deterioration
δ = 12- month score minus baseline score. The minimal important difference for the Asthma Quality of Life 
Questionnaire is 0.5, with higher scores indicating better quality of life. The minimal important difference 
for the Asthma Control Questionnaire is 0.5, with lower scores indicating better asthma control.
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discussion
We compared the clinical effectiveness of Internet-based self-management (as an 
adjunct to physician care) with usual physician-provided care alone. We offered all the 
components for optimal self-management (monitoring, education, medical review, 
and an action plan) through the Internet: electronic Internet-based symptom and lung 
function monitoring, access to an online personalized action plan, online education, 
and professional review using e-mail and private messaging. Our results suggest that 
Internet-based self-management of asthma improves quality of life, asthma control, and 
lung function and increases the number of symptom-free days compared with usual 
physician-provided care. 
To our knowledge, this is the first randomized, controlled evaluation of Internet-based 
asthma self-management that shows sustained improvement in asthma-related quality 
of life. The improvement achieved in the Internet group was as large as the minimal im-
portant difference with patients who reached optimal scores for asthma-related quality 
of life during 1-year follow-up (27). Two previous trials on Internet-based asthma man-
agement in adults and children, respectively, reported only short-term improvements 
on asthma-related quality of life (10, 11), whereas a 1-year, randomized, controlled trial 
that compared Internet-based and office-based asthma care in children did not show 
any changes in quality of life (9). Previous trials of paper-and-pencil self-management 
programs showed only moderate and inconsistent improvements on asthma-related 
quality of life (16, 17). 
For secondary end points, we consistently demonstrated clinically relevant improve-
ments in asthma control, lung function, and the percentage of symptom-free days. The 
beneficial clinical effects were reached without an increase in inhaled corticosteroid 
dose at 12 months. In the first 3 months, many patients had uncontrolled asthma and 
were advised to increase their inhaled corticosteroid doses. The improvement in asthma 
control seen after 3 months allowed a decrease in inhaled corticosteroid medication 
over the next 9 months without loss of asthma control. This pattern suggests tailoring 
medication to patients’ needs rather than increasing medication for the whole study 
sample. 
The process evaluation included outcomes on the principal components of asthma 
self-management. We showed improvements in asthma knowledge and inhalation 
technique in both groups for asthma education but without between-group differences. 
The improvements in the usual care group may be explained by the baseline meeting 
and measurements, which triggered patients to improve their asthma knowledge and 
inhalation skills. Other studies that assessed the behavioral effect of self-management 
programs found a similar result (9, 30). Basic education only, therefore, did not seem 
to be the key component explaining the positive effects of the Internet-based self-
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management intervention. The Internet group tended to have fewer annual physician 
visits. This was due to either increased asthma control in this group and therefore fewer 
requirements for medical review or physician visits may have been substituted by online 
contacts with our asthma nurse. By protocol, Internet-based monitoring only occurred 
in the intervention group. Patients reported symptoms and lung function once in 3 days 
and reported weekly asthma control in 35 of 52 weeks. The difference in the number of 
treatment changes between the groups may be explained by this frequency of monitor-
ing and subsequent treatment advice. 
Differences in the baseline characteristics, patient selection, participation rate, 
or underperformance of usual care do not seem to influence the results of this study. 
First, we found no statistically significant differences in the baseline characteristics 
between the 2 groups. Second, we selected patients from primary care practices and 
an outpatient subspecialty practice on the basis of a physician’s diagnosis of asthma. 
We cannot exclude the possibility that some patients did not meet the lung function or 
airway responsiveness criteria for a diagnosis of asthma, according to recent guidelines. 
However, in our study, as in a realistic routine care setting, we identified patients who 
were eligible for an asthma Internet-based self-management intervention through a 
physician’s diagnosis of asthma. Consequently, this might have diluted the effect of the 
Internet-based self-management intervention but enhanced the external validity of 
our study (31). Third, the participation rate was 21.5%, which is similar to rates in other 
asthma education and management studies (17, 32, 33). Age and socioeconomic status 
of non-participants were similar to those of participants, and women were only slightly 
overrepresented in the study sample. Demographic characteristics would suggest broad 
applicability in the general population; however, other important determinants of the 
non-participants were unknown. Patients with previously uncontrolled asthma are more 
likely to participate in a self-management program than are patients with well-controlled 
asthma (7). Structural barriers, such as lack of time; living too far; and social behavioral 
factors, such as self-efficacy, belief in personal benefits, and social influence, also predict 
participation in a self-management program (34). These clinical and psychological fac-
tors could have differed in participants and non-participants and might therefore have 
bearing on generalizability. In addition, about 20% of the population in the Netherlands 
does not have access to the Internet, which is an obvious reason for nonparticipation in 
our study. However, because Internet access is increasing worldwide, this barrier might 
disappear. Fourth, because we also saw improvements in asthma-related quality of life 
and control in the usual care group, although these did not reach statistical significance, 
it seems unlikely that our results can be explained by underperformance of physician-
provided care during the study compared with prestudy standards. 
A potential limitation of our study was that the patients and physicians were aware 
of the allocation group. Because asthma-related quality of life, asthma control, and 
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symptom-free days were self-reported, the improvements may have resulted from 
increased awareness rather than the Internet-based intervention. Furthermore, because 
the Asthma Control Questionnaire score was the target measurement that drove the 
treatment algorithm, we expected improvements. In addition, the absence of a differ-
ence in an objective outcome, such as exacerbations, does not support our positive find-
ings in patient-reported outcomes. However, this study was not designed or powered 
to detect a difference in exacerbation rate in patients with mild-to-moderate persistent 
asthma (24). Moreover, the improvement in lung function, as an objective measurement, 
provides a fair basis for our findings in quality of life, asthma control, and symptom-free 
days. 
The implications of our findings show that self-management of asthma guided by a 
validated, short questionnaire on asthma control, as recommended by recent guidelines, 
is feasible and improves quality of life. In addition, we demonstrate that the Internet is 
an effective way to disseminate knowledge to patients with asthma and a successful 
tool that can empower patients to achieve and maintain control of their asthma by 
adjusting treatment with effective medication. Our study further supports the emphasis 
that recent guidelines have placed on monitoring asthma control and illustrates that a 
relatively simple validated instrument, such as the Asthma Control Questionnaire, can 
be used to operationalize asthma control in guided self-management (1, 2, 14). Taken 
together, Internet-based self-management provides new ways to tailor monitoring and 
education continuously to patients’ needs, which empowers patients to control their 
asthma and to live full, normal, and active lives, even potentially in remote and under-
served populations in developed and developing countries (35). 
In conclusion, Internet-based self-management improves asthma-related quality of 
life, asthma control, and lung function and increases the number of symptom-free days. 
The challenge is implementing Internet-based self-management on a wider scale within 
routine asthma care.
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*At entry of the algorithm, the evaluation period is bypassed.
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appendix figure 2. Screen shot of daily lung function and symptom monitoring.
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appendix figure 3. Screen shot of feedback on daily lung function and symptom monitoring.
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appendix figure 4. Screen shot of weekly Asthma Control Questionnaire monitoring.
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appendix figure 5. Screen shot of feedback on Asthma Control Questionnaire, treatment advice 
according to personalized treatment plan and results of past 6 months.
CHAPTER 5
Weekly self-monitoring and treatment adjustment benefi t 
patients with partly controlled and uncontrolled asthma
Victor van der Meer, Henk F. van Stel, Moira J. Bakker, Albert C. Roldaan, 





Internet-based self-management has shown to improve asthma control and asthma 
related quality of life, but the improvements were only marginally clinically relevant for 
the group as a whole. 
objective 
We hypothesized that self-management guided by weekly monitoring of asthma con-
trol tailors pharmacological therapy to individual needs and improves asthma control 
for patients with partly controlled or uncontrolled asthma.
Methods 
In a 1-year randomised controlled trial involving 200 adults (18-50 years) with mild to 
moderate persistent asthma we evaluated the adherence with weekly monitoring and 
effect on asthma control and pharmacological treatment of a self-management algo-
rithm based on the Asthma Control Questionnaire (ACQ). Participants were assigned 
either to the internet group (n=101) that monitored asthma control weekly with the 
ACQ on the internet and adjusted treatment using a self-management algorithm super-
vised by an asthma nurse specialist or to the usual care group (UC) (n=99). We analysed 3 
subgroups: patients with well controlled (ACQ≤0.75), partly controlled (0.75>ACQ≤1.5) 
or uncontrolled (ACQ>1.5) asthma at baseline.
results
Overall monitoring adherence was 67% (95% CI, 60% to 74%). Improvements in ACQ 
score after 12 months were -0.14 (p=0.23), -0.52 (p<0.001) and -0.82 (p<0.001) in the 
internet group compared with usual care for patients with well, partly and uncontrolled 
asthma at baseline, respectively. Daily inhaled corticosteroid dose significantly increased 
in the internet group compared with usual care in the first 3 months in patients with un-
controlled asthma (+278 μg, p=0.001), but not in patients with well or partly controlled 
asthma. After one year there were no differences in daily inhaled corticosteroid use or 
long-acting β2-agonists between the internet group and usual care.
conclusions
Weekly self-monitoring and subsequent treatment adjustment leads to improved 
asthma control in patients with partly and uncontrolled asthma at baseline and tailors 
asthma medication to individual patients’ needs.
Targeting treatment on the basis of weekly asthma control self-monitoring 75
introduction
Recent international guidelines define asthma control in terms of two domains: impair-
ment and risk (1, 2). The distinction between these two domains for assessing asthma 
control emphasizes the need to consider separately patients’ functional capacity on an 
ongoing basis in the present and the risks for adverse events, such as side effects of 
medication, progressive lung function loss or exacerbations in the future. 
Ongoing monitoring of asthma control (both impairment and risk) is required to 
determine whether the goals of therapy are met (1, 3). Well-validated self-assessment 
questionnaires are available to periodically monitor the level of asthma control (4, 5, 6). 
Each of these instruments assess the impairment domain by measuring asthma symp-
toms, limitation of activities and need for rescue medication. However, lung function is 
only included in the Asthma Control Questionnaire (ACQ) (4). The periodic assessment 
of lung function is important, since it captures both asthma impairment at present and 
may detect future risk of progressive lung function and exacerbations (7, 8).
The frequency of periodic monitoring depends on the phase of treatment (9). At 
the initial phase intensive monitoring is required to evaluate the effect of treatment 
titration in order to achieve better asthma control. Once control has been achieved, the 
monitoring interval may be longer (9). Monitoring frequency and subsequent treatment 
decisions therefore depend on the level of asthma control and vice versa. 
We have conducted a trial in which the ACQ was used as a weekly monitoring tool 
and participants made treatment decisions according to an ACQ-based algorithm 
(10). Asthma control and asthma related quality of life improved compared with usual 
physician-guided care, but the improvements were only marginally clinically relevant for 
the group as a whole (10). In the present pre-planned analysis we investigated whether 
a simple index of asthma control can be used to predict the outcomes of internet-based 
self-management. We hypothesized that self-management guided by weekly monitor-
ing of asthma control tailors pharmacological therapy to individual needs and improves 
asthma control for patients with partly controlled or uncontrolled asthma. 
Methods
Patients
Full details of the study methodology and subjects for the Self-Management of Asthma 
Supported by Hospitals, ICT, Nurses and General Practitioners (SMASHING) project at 
baseline have previously been published (10). Briefly, the study enrolled 200 adults with 
asthma who were recruited from 37 general practices (69 general practitioners) in and 
around Leiden, The Netherlands, and from the outpatient department of Pulmonology 
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of the Leiden University Medical Center. We included patients with physician diagnosed 
asthma, aged between 18 and 50 years who had a prescription of inhaled corticosteroids 
for at least three months in the previous year.  We excluded patients on continuous oral 
glucocorticosteroids. The study was approved by the Medical Ethics Committee of the 
Leiden University Medical Center. All participants gave written informed consent.
design
This analysis is part of a prospective, randomised controlled cost-effectiveness trial 
(ISRCTN79864465) (10). Participants collected baseline data during a period of 2 weeks. 
They were trained to measure forced expiratory volume in 1 second (FEV1) daily with a 
hand-held electronic spirometer (PiKo1; Ferraris, UK) and were asked to report the high-
est value of three measurements in the morning on a designated Web application or by 
mobile phone text messaging. Along with the FEV1 value participants reported night 
time and daytime symptom scores. All participants were asked to complete the Asthma 
Control Questionnaire (ACQ) weekly on the Web application. During the baseline period 
participants received no feedback on lung function or clinical status. 
After the baseline period, patients were randomised to either internet-based self-
management (internet group) or usual physician-provided care (usual care group). The 
internet group was instructed to use a personal internet-based asthma action plan. This 
action plan required weekly completion of the ACQ via the internet for a period of 1 
year. After reporting the ACQ, participants instantly received a return message on the 
Website including advice on how to adjust treatment and a graphical representation of 
lung function and ACQ over time. 
Patients in the usual care group received asthma care according to the Dutch general 
practice guidelines on adult asthma management, which recommend follow-up consul-
tations every 2-4 weeks if asthma is not well controlled and medical review every year in 
well controlled asthma (11). These national guidelines are based on international recom-
mendations such as the GINA guidelines for asthma management and prevention (3).
After 3 months and 1 year both the internet and the usual care group collected 
asthma control data for a period of 2 weeks similar to the baseline period.
asthma control Questionnaire
The ACQ is a 7-item questionnaire that has been validated to measure asthma control (4). 
The items refer to asthma symptoms, rescue bronchodilator use and FEV1% of predicted 
normal. Responses are given on a 7-point scale and the overall score is the mean of the 
responses where 0 = totally controlled and 6 = severely uncontrolled.
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asthma therapy assessment Questionnaire – control index
The ATAQ is a 20-item questionnaire that generates indicators of problems in asthma 
care. The control index of the ATAQ contains 4 items that refer to asthma symptoms, 
activity limitation and rescue bronchodilator use in the past 4 weeks. Sum scores range 
from 0 (no control problems) to 4 control problems (1, 5).
treatment algorithm
Five pulmonologists, two general practitioners with special interest in respiratory disease 
and two respiratory epidemiologists participated in the development of the algorithm 
for the internet-based asthma action plan. This algorithm was based on consecutive 
weekly ACQ scores. Two previous studies identified cut-off points for levels of asthma 
control. Juniper et al reported a cut-point of 0.75 for patients with well controlled asthma 
and a cut-point of 1.50 for patients with uncontrolled asthma (13). Van den Nieuwenhof 
et al described cut-off points of 0.5, 1.0 and 1.5 to differentiate between the four severity 
levels of asthma in accordance with the GINA guidelines, although omitting the FEV1% 
of predicted normal (14).
Based on a clinically important difference of 0.5 the algorithm in our study uses three 
cut-points with 0.5 points differences: 0.5, 1.0 and 1.5 including the FEV1% of predicted 
normal (15). It provides instructions to increase treatment (step-up) or decrease treat-
ment (step-down) according to a pre-defined action plan. Figure 1 and table 1 show the 
treatment algorithm and action plan respectively. In brief, treatment step-up is advised 
when the ACQ score is above 1.0 once or between 0.5 and 1.0 twice consecutively and 
treatment step-down is advised after four weeks of ACQ scores below 0.5. When the 
ACQ score is above 1.5 the algorithm additionally advises to contact the asthma nurse 
or other health care provider. An evaluation period of four weeks without treatment 
table 1. Treatment steps for the internet-based asthma action plan (10)
Step* Medication
1 As needed rapid-acting β2-agonist†
2 Low-dose inhaled glucocorticosteroids
3a Low-dose inhaled glucocorticosteroids plus long-acting β2-agonist
3b Medium-dose inhaled glucocorticosteroids
3c High-dose inhaled glucocorticosteroids
4a Medium-dose inhaled glucocorticosteroids plus long-acting β2-agonist
4b High-dose inhaled glucocorticosteroids plus long-acting β2-agonist
4c Contact asthma nurse‡ : consider addition of leukotriene modifier
5 Contact asthma nurse‡ : consider addition of oral glucocorticosteroid
*  Step numbers correspond with recommended steps in GINA guidelines figure 4.3-2.(3).
†  Applies to all treatment steps.
‡  Or other health care provider.
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changes follows after step-up instruction. Step-down instruction is followed by a period 
of four weeks (step-down period) in which no second step-down can be advised, but in 
case of deteriorating asthma, a treatment step-up is possible in this period.
Monitoring adherence
Monitoring adherence was defined as the proportion of weekly completed internet-
based ACQs in the internet group in each month of follow-up. We analyzed three 
subgroups of patients to allow evaluation of adherence for different levels of asthma 
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control at baseline: well controlled (ACQ < 0.75), partly controlled (ACQ ≥ 0.75 to < 1.5) 
or uncontrolled asthma (ACQ ≥ 1.5) (1, 13). 
outcome measures
Asthma control was the primary outcome. Asthma control was calculated as the aver-
age of ACQ scores during the two-week baseline and two-week end periods. The ATAQ 
control index acted as a measure of construct validity. 
Secondary outcome measures were the mean daily dose of inhaled corticosteroid 
(ICS), and the proportion of participants using long-acting β2-agonists (LABA) or leuko-
triene receptor antagonists (LTRA). Inhaled corticosteroid doses were reported as flutica-
sone equivalents. Data on pharmacological treatment were obtained from self-reports 
at baseline and after 3 months and 1 year. 
We analyzed three subgroups of patients to allow evaluation of the treatment al-
gorithm for different levels of asthma control at baseline: well controlled (ACQ < 0.75), 
partly controlled (ACQ ≥ 0.75 to < 1.5) or uncontrolled asthma (ACQ ≥ 1.5) (3, 13).
sample size
With the 100 participants per study group and a standard deviation of changes in ACQ 
score of 0.69 we were able to detect at least a 0.28 difference between ACQ score changes 
in the two study groups (significance level 0.05 two-sided; power 0.80 one-sided) (16). 
A clinically important decrease in ACQ score of at least 0.50 could thus be detected if at 
least 30 participants were present per subgroup (15).
statistical analysis
Differences in ACQ scores and inhaled corticosteroid doses between internet and UC 
groups at two time points (3 and 12 months) were analyzed using multivariate linear 
regression modelling with a random intercept to adjust for repeated measures (17). 
The construct validity of the ACQ as an outcome measure was evaluated by Pearson’s 
correlation coefficients: 1) between ACQ and ATAQ control index at baseline and 12 
months and 2) between change scores (12 months minus baseline value) of ACQ and 
ATAQ control index. 
Differences in the proportion of patients using long-acting β2-agonists or leukotriene 
receptor antagonists between the two groups and at the two different time point were 
analyzed using multivariate population averaged logistic regression analysis with a 
random intercept (17). Covariates in both regression models were baseline values of the 
appropriate outcome parameter, sex, age, education level, smoking status and type of 
care provider. 
All analyses were carried out on an intention-to-treat basis. We used the statistical 
software package STATA 9.0 (StataCorp; College Station TX, US). 
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results 
Figure 2 summarizes the participant flow during enrolment, allocation and follow-up 
(figure 2). A total of 200 consented to participate in the randomised controlled study: 
75 patients had well controlled asthma, 71 had partly controlled asthma and 54 had un-
controlled asthma at baseline (table 2). Mean age was 36.3 and 31% was male. Smoking 
was reported more often in patients with uncontrolled asthma (33% current smokers) 
than in patients with partly controlled (8%) or well controlled asthma (3%). The ACQ at 
baseline was 0.43, 1.10 and 2.09 for the three groups, respectively. Inhaled corticosteroid 
use at baseline was 448, 483 and 620 µg/day, respectively. The use of long-acting β2-
agonists was similar for the groups with partly and uncontrolled asthma (62% and 63%), 
and only slightly higher than in patients with well controlled asthma (55% long-acting 
β2-agonists use). Five patients used leukotriene receptor antagonists: one in the group 
with well controlled asthma, two in the group with partly controlled asthma and two in 
the group with uncontrolled asthma.
Monitoring adherence
Overall monitoring adherence was 67% (95% CI, 60 to 74%). Adherence to ACQ monitor-
ing gradually declined from the first month (88%) to the seventh month (60%) and then 





























































































































































































































































































































































































































































































































































































































































































































































remained stable up to 1 year. Monitoring in the three subgroups was 71%, 68% and 58% 
during the one-year follow-up for well, partly and uncontrolled asthma, respectively 
(figure 3).
figure 3. Monitoring adherence (percentages) for patients with well controlled (n=75), partly controlled 

























There were no deviations from random allocation. At baseline 75 participants had well 
controlled asthma, 71 partly controlled and 54 participants had uncontrolled asthma. 
ACQ scores at 12 months were provided by 69 (92%), 69 (97%) and 44 (81%) participants, 
respectively. 
Figure 4 shows the ACQ scores at baseline, 3 and 12 months of follow-up in the UC 
and internet group for each baseline control level (figure 4). In patients with well con-
trolled asthma at baseline ACQ scores were not significantly different between the usual 
care and internet group during follow-up. In patients with partly controlled asthma at 
baseline ACQ scores in the internet group improved with -0.44 (95% CI, -0.67 to -0.22) 
and -0.51 (-0.73 to -0.29) after 3 and 12 months, respectively, compared with usual care. 
In patients with uncontrolled asthma at baseline ACQ scores in the internet group im-
proved with -0.57 (95% CI, -0.84 to -0.31) and -0.82 (-1.10 to -0.55) after 3 and 12 months, 
respectively, compared with usual care. Correlations between ACQ and ATAQ control 
index were 0.57 (p<0.001) and 0.64 (p<0.001) at baseline and 12 months, respectively. 
The correlation of change scores was 0.52 (p<0.001).
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Pharmacological therapy
Figure 5 shows the daily dose of inhaled corticosteroid (ICS) at baseline, 3 and 12 
months of follow-up in the usual care and internet group for each baseline control level 
(figure 5). In patients with well controlled asthma at baseline the ICS dose increased 
non-significantly, followed by a significant decrease from 3 to 12 months (p=0.042). At 
12 months the ICS dose was similar for both groups: difference -9 µg (95% CI, -147 to 
130). In patients with partly controlled asthma at baseline the ICS dose increased in the 
first 3 months and decreased in the next 9 months in the internet compared to the usual 
care group, both changes being non-significant. At 12 months the ICS dose did not differ 
between the groups: difference 54 µg (95% CI, -86 to 194). Patients with uncontrolled 
asthma showed a significant increase in the first 3 months (278 µg, p=0.001) followed 
by a significant decrease in the next 9 months (-149 µg, p=0.043) in the internet group 
compared with usual care. At 12 months the ICS dose was not significantly higher in the 
internet group compared with usual care: difference 130 µg (95% CI, -43 to 303).
The number of patients using LABA or LTRA was not significantly different between 
the three baseline control levels and are therefore presented altogether (figure 6). The 
proportion of patients using LABA was similar for the internet and usual care group at 3 
months (63% internet and 62% usual care; p = 0.60) and 12 months (64% internet and 
58% usual care, p = 0.11), adjusted OR: 1.61 (95% CI, 0.74 to 3.48).
figure 4. ACQ scores during study follow-up for patients with well controlled (panel I; n=75), partly 
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figure 5. Mean daily dose of inhaled corticosteroids (μg) during study follow-up for patients with well 
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figure 6. Percentage of patients using long-acting β2-agonists (laba) or leukotriene receptor antagonists 
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Figure 6 shows that only a few patients used LTRA. The proportion of patients using 
LTRA was significantly higher for the internet group than usual care at 3 months (9% vs 
2%, adjusted OR: 6.03 (95% CI, 1.03 to 35.4)), but not at 12 months (10% vs 4%, adjusted 
OR: 2.63 (95% CI, 0.67 to 10.3)).
discussion
This analysis provides insight into the effects of internet-based self-management 
guided by an electronic algorithm based on weekly assessment of asthma impairment 
on process outcomes for three different levels of asthma control at baseline. Adherence 
to the internet-based monitoring instrument was 67%. The results show a considerable 
improvement in asthma control for patients with partly controlled or uncontrolled 
asthma at baseline without significant increases in inhaled corticosteroids, long-acting 
β2-agonists or leukotriene receptor antagonist use at 12 months. 
This is the first randomised controlled evaluation of asthma self-management guided 
by a short validated questionnaire on asthma control. By guiding treatment on the basis 
of short interval monitoring of asthma control we were able to adopt recommended 
treatment strategies into an asthma action plan (1, 3). The current analysis reveals three 
important findings regarding asthma control, pharmacological therapy and monitoring 
adherence in the three subgroups of patients with different levels of asthma control at 
baseline.
First, the improvements in asthma control scores for patients with partly or un-
controlled asthma at baseline suggest a significant reduction of current functional 
impairment. Remarkably, control scores stabilised or even continued to improve after 
3 months, while ICS doses decreased in patients with well or uncontrolled asthma 
at baseline. A possible explanation is that to achieve asthma control higher doses of 
anti-inflammatory therapy are needed than to maintain asthma control (3). The reduced 
need for ICS may decrease future risk for side effects of medication. 
Second, this asthma action plan is one of few that not only specifies action points 
to increase, but also to decrease treatment, which provides the possibility to tailor 
medication to individual needs. All three baseline control level groups showed a similar 
pattern of pharmacological therapy over time: an increase in inhaled corticosteroids 
in the first three months, followed by a decrease in the next 9 months. However, the 
different magnitudes of the increases and decreases reflected tailoring of medication 
to individual patients’ needs rather than a mere increase of medication for the whole 
population. It can be seen that only for patients with uncontrolled asthma at baseline 
the inhaled corticosteroid dose significantly increased after three months. 
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Third, this study showed that weekly internet-based monitoring is feasible in terms of 
monitoring adherence. In the groups with well and partly controlled asthma at baseline 
monitoring adherence of about 80% in the first 3 months decreased to 60% during the 
last months of follow-up. Despite declining monitoring adherence, asthma remained 
adequately controlled. This reflects the reduced need for monitoring once control of the 
disease has been achieved (9). Patients with uncontrolled asthma at baseline monitored 
asthma control in 80% during the first 3 months (similar to patients with well and partly 
controlled asthma). However, in this group monitoring adherence declined to below 
50% and asthma control did not reach the good control scores (below 0.75) as it did in 
the well and partly controlled groups. Efforts to optimise monitoring adherence may 
further increase asthma control. 
Two methodological issues are of particular interest. The outcomes of our study were 
patient reported. Patient reported outcomes may have a risk of reduced validity com-
pared to objective outcomes. We therefore evaluated the correlations of our outcome 
measure of asthma control with another asthma control index (5). The moderate to 
good correlations of both cross-sectional scores and change scores not only illustrated 
the effectiveness of a potent algorithm, but also demonstrated a satisfactory construct 
validity of this algorithm. With regard to medication reports, we asked patients to bring 
their inhalers at baseline and end visits, which enhanced the validity. However, patients 
may have reported different numbers of puffs than actually used or other types of 
inhalers than they actually brought to the visits. Second, we recognize that the effect 
of the internet-based self-management intervention can not solely be attributed to our 
treatment algorithm. We emphasize that, except for asthma monitoring and a medi-
cal treatment plan, a self-management asthma support programme should consist of 
asthma education, environmental control and medical review (18).
To conclude, weekly self-monitoring and subsequent treatment adjustment leads to 
improved asthma control in patients with partly and uncontrolled asthma at baseline 
and tailors asthma medication to individual patients’ needs. Future asthma treatment 
strategies should incorporate continuous self-monitoring with use of a short validated 
questionnaire on asthma control.
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CHAPTER 6
Cost-eff ectiveness of internet-based self-management 
compared with usual care in asthma
Victor van der Meer, Wilbert B. van den Hout, Moira J. Bakker, Klaus F. Rabe, 





Effectiveness of internet-based self-management in patients with asthma has been 
shown, but its cost-effectiveness is unknown. We conducted a cost-effectiveness analy-
sis of internet-based asthma self-management compared with usual care.
Methods
Cost-effectiveness analysis alongside a randomized controlled trial, with 12 months 
follow-up. Patients were aged 18 to 50 year and had physician diagnosed asthma. 
The internet-based self-management program involved weekly on-line monitoring of 
asthma control with self-treatment advice, remote Web communications, and internet-
based information. We determined quality adjusted life years (QALYs) as measured by 
the EuroQol-5D and costs for health care use and absenteeism. We performed a detailed 
cost price analysis for the primary intervention. 
results
QALYs improved for internet-based self-management compared with usual care with 
0.024 (-0.016 to 0.065). Costs of the internet-based intervention were $254 ($243 to 
$265) during the period of 1 year. From a societal perspective, costs were $641 (95% CI, 
$-1957 to $3240) higher in the intervention group, with a cost-utility ratio of $26700 per 
QALY. From a health care perspective, total costs were $37 (95% CI, $-874 to $950) higher 
in the intervention group, with a cost-utility ratio of $1500 per QALY. At a willingness-
to-pay of $50000 per QALY, the probability that internet-based self-management was 
cost-effective compared with usual care was 62% and 82% from a societal and health 
care perspective, respectively.
conclusions
The results suggest that internet-based self-management in asthma is cost-effective 
compared with usual care, even more so from a health care perspective than from a 
societal perspective.
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introduction
Asthma is a chronic, inflammatory disorder  of the airways clinically characterized by 
respiratory symptoms such as wheeze, cough, dyspnoea, chest tightness and impaired 
lung function (1, 2). Treatment for asthma is aimed at improving asthma control, i.e. 
reducing current symptoms and need for short-acting bronchodilation, improving lung 
function and preventing future exacerbations (1-3).
In the past decade, the care for asthma patients has shifted from physician-managed 
care to guided self-management. Guided self-management includes asthma education, 
self-monitoring of symptoms and/or lung function and adjustment of treatment accord-
ing to an action plan guided by a health care professional (not necessarily a physician). 
Self-management has been shown to improve asthma control and quality of life and 
reduce health care utilization and sometimes improve lung function (4). 
Besides clinical effectiveness, the implementation of new disease management strat-
egies requires an economic evaluation to determine whether the clinical benefits are 
gained at reasonable costs. Several cost evaluations have compared paper-and-pencil 
self-management plans to usual care in asthma (5-11), but only a few compared costs to 
quality of life (10-11). Most of these economic evaluations found that written self-man-
agement plans for asthma were likely to be cost-effective compared with usual physi-
cian provided care. However, the implementation of paper-and-pencil self-management 
plans is hampered by patients’ and doctors’ reluctance to use written diaries (12).
Implementation of guided self-management programs may be enhanced by the 
use of internet-based technologies, particularly in remote and underserved areas. In 
a recently conducted randomized controlled trial we have shown that internet-based 
self-management is feasible and provides better clinical outcomes compared with usual 
physician provided care with regard to asthma related quality of life, asthma control, 
symptom-free days and lung function (13). Although previous trials have also evaluated 
the clinical effects of internet-based self-management in adults (14) and children (15, 
16), so far, no economic evaluations have been conducted. We therefore carried out a 
cost-utility analysis, comparing quality of life with societal and health care costs during 
one year, to determine whether the clinical benefits gained with internet-based self-
management are attained at reasonable costs. 
Methods
setting and participants
Two hundred patients participated in a 12-month multicenter, non-blinded, randomized 
controlled trial.  Patients were recruited from 37 general practices (69 general practitio-
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ners) in the Leiden and The Hague area and the Outpatient Clinic of the Department of 
Pulmonology at the Leiden University Medical Center, The Netherlands over the period 
from September 2005 to September 2006 (13). We included patients with physician 
diagnosed asthma as coded according to the International Classification of Primary Care 
in the electronic medical record (17), aged 18-50 years, with a prescription of inhaled 
corticosteroids for at least three months in the previous year, access to internet at home, 
mastery of the Dutch language and without serious co-morbid conditions that interfered 
with asthma treatment. Patients on maintenance oral glucocorticosteroid treatment 
were excluded. All participants gave their written consent. The study was approved by 
the Medical Ethics Committee of the Leiden University Medical Center.
Details of the randomization and intervention have been described previously (13). 
Briefly, the 200 patients were randomly assigned to internet-based self-management as 
an adjunct to usual care (internet group: 101 patients) or to usual physician-provided 
care alone (usual care group: 99 patients). Allocation took place by computer after 
collection of the baseline data, ensuring concealment of allocation. The internet-based 
self-management program included weekly monitoring of asthma control and lung 
function, immediate treatment advice according to a computerized personal action 
plan after completing the validated Asthma Control Questionnaire on the internet 
(18), on-line education and group-based education, and remote Web communication 
with a specialized asthma nurse. After one year, asthma related quality of life (Asthma 
Quality of Life Questionnaire (19)), asthma control and lung function showed a clinically 
relevant and statistically significant improvement in the internet group compared to the 
usual care group (13).
utilities and Qalys
Utilities express the valuation of health-related quality of life on a scale from zero 
(death) to one (perfect health). Patients described their health-related quality of life 
using the EuroQol classification system (EQ-5D) (20), from which we calculated their 
utilities over time using the British tariff (21). The area under the utility curve is known 
as quality-adjusted life years (QALY) and was used as the primary outcome measure for 
the cost-effectiveness analysis. Patients additionally valued their own health status on a 
visual analogue scale (VAS). This scale from the patient perspective is potentially more 
responsive to change than other generic quality of life instruments, but is not the best 
choice for economic evaluations from a societal perspective (22). The VAS scale was 
transformed to a utility scale using the power transformation 1 – (1-VAS/100)1.61 (23).
We obtained utility measurements at baseline, 3 and 12 months. For EQ-5D measure-
ments 6.5%, 10% and 8.5% were missing and for visual analogue measurements 7%, 
10% and 9% were missing at 0, 3 and 12 months, respectively. To correct for possibly 
selective non-response, missing measurements were replaced by 5 imputed values 
Cost-effectiveness of internet-based self-management in asthma 93
based on switching regression (24, 25) with regression variables randomisation group, 
age, sex, asthma control at baseline and available utility measures at all time points. 
We estimated the intervention effect for each of the 5 data sets by a linear regression 
model with randomisation group as only independent variable, combining the multiple 
imputation sets using Rubin’s rules (26).
costs
We distinguished three major cost categories: intervention costs, other health care 
costs and productivity costs (10, 11). Intervention costs consisted of materials (software 
support, electronic spirometer), personnel and patient costs (travel, time, internet and 
text messaging costs). Other health care costs included contacts (including face-to-face, 
telephonic and home contacts) with health care professionals (general practitioners, 
chest physician, other specialists, physiotherapists, psychologists, complementary care 
and other paramedical professionals), emergency room visits, hospital admissions and 
both asthma and non-asthma medication.
Patients reported their use of health care resources and the hours of absence from 
work using a quarterly cost-questionnaire. Details of the drugs used were derived from 
pharmacy records. We used standard prices for units of resource use and hours of ab-
senteeism (27, 28), which were converted to the price level of 2007 according to the 
general Dutch consumer price index (29) and converted to US dollars using the purchas-
ing power parity index (€1 = $1.131) (30). Because of the one-year time horizon, costs 
were not discounted.
Cost-questionnaires were scheduled to be handed in at 3, 6, 9 and 12 months. Of 
these quarterly questionnaires, 10%, 14%, 19% and 9% were missing, respectively. 
Pharmacy records were available for 182 patients (91%). Missing cost-questionnaire 
and pharmacy record were imputed using multiple imputation, as previously described 
under ‘Utilities and QALYs’.
statistical analysis 
The base case cost-effectiveness analysis compared societal costs with QALYs gained 
based on the British EQ-5D over the period of one year. Because of the limited degree of 
modelling in this cost utility analysis, we carried out sensitivity analyses only on the use 
of different utility measures (British EQ-5D or Visual Analogue Scale) and on the included 
cost categories (societal or health care perspective). 
Differences and statistical uncertainty of QALYs and costs were calculated using non-
parametric bootstrap estimation with 5000 random samples (1000 from each of the 5 
imputations). Statistical uncertainty of the cost-effectiveness was analyzed using the net 
benefit approach (31). The net benefit (NB) is defined as WTP x ΔQALY – Δcosts, where 
WTP is the willingness to pay for a QALY gained. This approach reformulates the QALY 
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difference into a monetary difference. In a cost-effectiveness acceptability curve we 
graphed the probability that the internet-based self-management program was cost-
effective compared with usual care as a function of WTP and reported this probability at 
commonly cited WTP values of $50000 and $100000 per QALY (32).
Analyses were carried out with Stata 9.0 (StataCorp, College Station, TX).
results
The internet group and usual care group consisted of 101 and 99 participants, respec-
tively. Mean age of the sample was 37 years and 70% of the participants were women 
(table 1). At baseline, asthma related quality of life, asthma control and medication use 
were similar for the two randomization groups. 
table 1. Baseline characteristics





Age, years 37 (18-50) 36 (19-50)


















FEV1 (pre-bronchodilator), L 3.13 (1.56-5.23) 3.08 (1.14-5.19)
FEV1 (pre-bronchodilator), % predicted 90 (53-118) 88 (34-133)
Inhaled corticosteroid dose, μg/day 517 (0-2000) 494 (0-1000)
Inhaled long-acting β2-agonist, % of patients 60% 59%
Leukotriene modifier, % of patients 2% 3%
Clinical outcomes
 Asthma Quality of Life Questionnaire *












Data are mean (range) unless otherwise indicated. * Range 1 (worst) – 7 (best) (19). † Range 0 (best) – 6 
(worst) (18). ‡ EQ-5D = EuroQol questionnaire, 5 dimensions (20). Parts of this table were published 
previously (13).
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utilities and Qalys
At baseline, the utilities according to the EQ-5D were non-statistically significantly 
higher for the internet group than for the usual care group. EQ-5D utilities did not reach 
a statistical significant difference throughout the study. At 3 months and 12 months 
the difference in EQ-5D utility was 0.037 (-0.007 to 0.081) and 0.006 (-0.042 to 0.054), 
respectively, in favour of the internet group. Quality adjusted life years gained in the 
internet group were estimated to be 0.024 (-0.016 to 0.065) compared to the usual care 
group (table 2).
Similarly, visual analogue scale utilities were not statistically significantly different 
throughout the study. At 3 and 12 months the difference in visual analogue scale utility 
was 0.012 (-0.026 to 0.050) and 0.013 (-0.015 to 0.040), respectively, in favour of the 
internet group. Quality of life years gained based on the visual analogue scale were 
estimated to be 0.007 (-0.017 to 0.032) in favour of the internet group (table 2).
table 2. Utilities at 0, 3 and 12 months and QALYs *
Variable Usual care group Internet group Difference (95% CI) P value
EQ-5D
0 months 0.89 0.91 0.026 (-0.024 to 0.076) 0.31
3 months 0.89 0.93 0.037 (-0.007 to 0.081) 0.099
12 months 0.91 0.92 0.006 (-0.042 to 0.054) 0.80
QALYs 0.90 0.92 0.024 (-0.016 to 0.065) 0.25
Visual analogue scale †
0 months 0.87 0.86 -0.013 (-0.045 to 0.019) 0.43
3 months 0.87 0.89 0.012 (-0.026 to 0.050) 0.54
12 months 0.88 0.89 0.013 (-0.015 to 0.040) 0.37
QALYs 0.88 0.88 0.007 (-0.017 to 0.032) 0.57
* Values are summary estimates of the 5 data sets obtained by multiple imputation, combined using 
Rubin’s rules. † Transformed using the power transformation 1 – (1-VAS/100)1.61 (23)
costs
The total intervention costs were estimated at $25675, which is $254 (95% CI, $243 to 
$265) per patient (table 3). The highest cost components of the internet-based interven-
tion were software support ($7917) and the patients’ time costs ($5380 for monitoring 
time and $5106 for attending the education sessions).
The difference in other health care costs amounted to $-217 (95% CI, $-1117 to $682) per 
patient indicating (non-significant) cost savings for the internet group (table 4). Patients 
in the internet group had fewer contacts with health care providers than patients in 
the usual care group. Particularly, reductions in contacts with physiotherapists ($-120, 
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p=0.03) and contacts with general practitioners ($-69, p=0.18) resulted in cost reduc-
tions for the internet group. In contrast, costs for medication were higher in the internet 
group due to increased use of inhaled corticosteroid/long-acting β2agonist combina-
tions ($82, p=0.09) and leukotriene antagonists ($25, p=0.12). The difference in other 
health care costs was similar in size to the opposite difference in intervention costs, 
resulting in a negligible difference in health care costs of $37 (95% CI, $-874 to $950), 
slightly in favour of usual care.
Patients in the internet group reported 114 hours of absence from work compared 
to 98 hours for patients in the usual care group. The 16 hours difference in absenteeism 
was estimated to be equivalent to $604 (95% CI, $-1430 to $2637) in monetary terms. 
The difference in societal costs (i.e. health care costs plus costs due to absenteeism) was 
therefore estimated at $641 (95% CI, $-1957 to $3240) in favour of usual care. 
cost-utility analysis
From a societal perspective, costs were in favour of usual care and QALYs, based on the 
EQ-5D, were in favour of internet-based self-management. According to this base case 
analysis, the cost-utility ratio was $26700 per QALY. Due to statistical uncertainty of both 
costs and QALYs, the probability that internet-based self-management is cost-effective 
compared with usual care depends on the willingness-to-pay per QALY. This probability 
was 62% at $50000 per QALY and 74% at $100000 per QALY (figure 1). From a health care 
perspective, the lower health care costs result in a cost-utility ratio of $1500 per QALY. 
table 3. Implementation costs ($) of internet-based self-management intervention











 development educational aids
 education sessions











 travel costs for sessions
 time costs for sessions (incl. travel time)
 time costs for monitoring * 
 internet log in costs † 
 mobile phone costs ‡
6 / session
20 / session
0.50 / log in












Total implementation costs 25675
Total implementation costs per patient 254
* Monitoring time was estimated at 3 minutes per log in and valued at $10 per hour, i.e. the Dutch 
standard price for unpaid labour (27). Number of units was obtained from internet log files. † Internet 
costs were valued at $23 per month. ‡ Mobile phone costs were valued at $0.20 per message.
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The probability that internet-based self-management is cost-effective from a health care 
perspective was 82% at $50000 per QALY and 86% at $100000 per QALY (figure 1).
QALYs gained, based on the visual analogue scale, were less than those based on the 
EQ-5D. In this case cost-utility ratios were $91600 per QALY and $5300 per QALY from a 
societal and health care perspective, respectively.
discussion
In this study we evaluated the cost-effectiveness of a new disease management strategy, 
internet-based self-management, for patients with asthma. The internet group non-sta-
tistically significantly gained 0.024 QALY during a follow-up period of 1 year compared 
with usual care. Costs were $641 higher from a societal perspective, with an estimated 
table 4. Average health care costs and societal costs per patient ($)
Usual care group Internet group Difference
Volume Costs Volume Costs Costs P Value
Intervention costs - - 1 254 254 <0.001













 Inhaled corticosteroids (ICS)
 Long-acting β2-agonists (LABA)










































































































Subtotal other health care costs 2518 2300 -217 0.63
Total health care costs 2518 2555 37 0.94
Productivity costs † 98 hr 3131 114 hr 3735 604 0.56
Total societal costs 5647 6289 641 0.63
* Volumes of drugs represent percentage of patients. † Volumes of productivity costs are number of hours 
of absence from work
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cost-utility ratio of $26700 per QALY, which is generally considered acceptable. Both the 
estimation of QALYs gained and the calculated expenses showed considerable uncer-
tainty, which is displayed by the probability curves. At a commonly cited willingness-to-
pay threshold of $50000 per QALY (32) the internet-based self-management intervention 
had a probability of 62% and 82% to be cost-effective compared with usual care from a 
societal perspective and health care perspective, respectively. 
We have previously shown substantial and statistically significant clinical effects 
in favour of internet-based self-management with regard to asthma related quality of 
life, asthma control and lung function (13). Although the utility outcomes presented 
in the current study point in the same direction (i.e. in favor of internet-based self-
management) as the clinical outcomes, their statistical significance is less evident. 
There are two main reasons that may explain this finding. First, generic quality of life 
measures, such as the EQ-5D, must be distinguished from disease-specific quality of life 
measures, such as the Asthma Quality of Life Questionnaire (19). The latter is well known 
to be responsive to change (22). However, generic preference-based instruments may 
differentiate between the highest en lowest levels of asthma control, but are less able 
to discriminate between moderate levels (33, 34). The baseline asthma control scores 
found in our primary care study population can be classified as moderately or partly 
controlled asthma and substantial improvements in disease-specific quality of life may 
have been missed by the generic instruments. Second, the absence of a statistically sig-
nificant difference in our primary utility measure may reflect a lack of statistical power, 
since our trial was powered to detect a statistical difference in the primary outcome 
figure 1. Cost-effectiveness acceptability curves, i.e. the probability that internet-based self-management 
is cost-effective compared with usual care depending on the willingness-to-pay per QALY from a societal 
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measure, asthma related quality of life, and not explicitly to detect differences in generic 
preference-based utility measures (13, 35). 
The intervention costs of $254 per patient were similar to intervention costs of a 
paper-and-pencil asthma self-management program (10), but were half of the costs of 
intensive nurse-led telemonitoring in asthma reported by others (11). The costs of the 
technological innovation (software support, electronic spirometer, internet and mobile 
phone costs) were only about 40% of the total intervention costs. The fixed technologi-
cal costs of software support constituted about one third of the intervention costs, so 
a considerable increase in the number of users could reduce the cost per user by one 
third. Moreover, the calculations were based on costs during the one-year randomized 
controlled trial. Asthma self-management cost-effectiveness studies with a longer time 
horizon have shown that intervention costs decrease after the first year (10, 36). In our 
study, costs for education sessions only apply to the first year, thus reducing costs in 
later years by about a quarter.
The other health care costs show a reduction of contacts with health care providers 
in the internet group. Although this reduction is consistently observed in 9 out of 10 
health care providers, only the reduction in contacts with physiotherapists were statisti-
cally significant, suggesting that patients with better asthma control are less in need 
for physiotherapy. The cost of drugs for asthma show small decreases in short-acting 
β2-agonists and inhaled corticosteroids along, but increases in combination therapy 
(inhaled corticosteroids plus long-acting β2-agonists) and leukotriene antagonists in the 
self-management group. This finding, in combination with favorable clinical outcomes 
of the internet-based self-management group, suggests that asthma medication was 
used more efficiently by those in the internet group.
Our study had several limitations. First, quality adjusted life year estimates were 
calculated from only two follow-up measurements. More measurements would possibly 
have resulted in more accurate QALY estimates, but we limited the number of follow-up 
measures in order to minimize the awareness of participating in a clinical trial among 
patients in the usual care group. Second, patients were inevitably aware of the allocated 
group, which may have influenced their utility ratings. Third, our economic evaluation 
was limited to one year. As pointed out above a longer duration would probably have 
resulted in reduced intervention cost estimates after one year. It is, however, unknown 
how EQ-5D utility scores will progress after one year. 
New cost-effective disease management strategies for asthma are required to face 
up to the global burden of asthma. Internet-based self-management is an innovative 
and effective management strategy in adults with asthma that improves clinical out-
come. The results of the current study suggest that internet-based self-management is 
cost-effective compared with usual care, even more so from a health care perspective 
than from a societal perspective.
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suMMary
This thesis describes the role of internet-based support in the delivery of an asthma 
self-management program. First, the compliance and reliability of home lung function 
monitoring, one of the key features of asthma self-management, was studied. Second, 
we explored intrinsic barriers to current asthma management and revealed possible 
benefits from internet-based asthma self-management. Third, we assessed the clinical 
effectiveness and cost-effectiveness of an internet-based asthma self-management pro-
gram over a period of 1 year. The conclusions from our studies are summarised below.
• Compliance and reliability of home peak flow measurements by adolescents using 
the internet or short message service is high over a 4-week period (chapter 2).
• Limited self-efficacy to control asthma is the main barrier to current asthma manage-
ment in adolescents with poor asthma control (chapter 3).
• Adolescents consider feasible electronic monitoring, easily accessible information, e-
mail communication and the use of an electronic action plan to be the main benefits 
of internet-based self-management (chapter 3).
• Asthma knowledge, inhaler technique and self-reported medication adherence are 
similarly improved by internet-based self-management as compared with usual 
physician-provided care. Internet-based self-management may reduce doctor visits 
and the number of medication changes is increased (chapter 4).
• Internet-based self-management improves asthma related quality of life, asthma 
control, symptom-free days and lung function, but does not decrease the number of 
exacerbations (chapter 4).
• Self-management based on weekly assessments of asthma control leads to improved 
asthma control in patients with partly and uncontrolled asthma at baseline and tailors 
asthma medication to individual patients’ needs (chapter 5).
• Internet-based self-management is cost-effective compared with usual care, even 
more so from a health care perspective than from a societal perspective (chapter 6).
general discussion
telemonitoring; how, what and how often?
How?
In all presented studies home telemonitoring played a pivotal role. Previous reports 
on paper-and-pencil peak flow diaries showed poor compliance and more than 40% 
erroneous reports (1, 2). We intended to use an electronic spirometer as part of the 
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self-management program. Therefore, we evaluated the compliance and reliability of 
electronic home peak flow monitoring and reporting. The adolescents in our obser-
vational study reported peak flow values on 90% of the days during 4 weeks (chapter 
2). Comparison of the values with those in the memory of the electronic spirometer 
revealed that about 80% of reported values were correct. However, we observed a de-
crease in compliance and increase in erroneous reports over time which had not reached 
a plateau by week 4. Most likely this course over time was due to the lack of feedback 
or therapeutic consequences following peak flow reporting. Previous studies, using 
electronic monitoring in order to guide therapy, showed continuing high compliance 
rates compared to paper-and-pencil diaries (3, 4). Therefore, we recommend electronic 
monitoring rather than written diaries in order to evaluate lung function in research and 
clinical practice settings.
What?
The electronic spirometer used in our studies (PiKo; Ferraris, UK) also measures FEV1. 
Compliance and reliability of the FEV1 reports were similar to the peak flow reports in 
our 4-week observational study. Its good validity had been shown earlier (5). The avail-
ability of a home lung function device which measures not only peak flow, but also FEV1 
opened up ways to measure validated composite control scores, such as the Asthma 
Control Questionnaire (ACQ), at home (6). Several studies have compared written versus 
electronic respiratory questionnaires and generally found high concordance (7-9).
How often?
The use of composite control scores, such as the ACQ, has the advantage of not only 
capturing one or more (randomly chosen) elements of asthma control, but providing 
one single score for the level of asthma control, taking into account asthma symptoms, 
limitations in activity, quick reliever use and lung function. Since the ACQ addresses 
asthma symptoms and quick reliever use during the past week, we created an asthma 
action plan algorithm based on weekly consecutive ACQ measurements. Overall, ACQ 
monitoring adherence was 67%. We observed a decline in monitoring adherence from 
88% in the first month to 60% in the seventh month and after that adherence remained 
stable (chapter 5). Despite the decline in monitoring adherence, asthma remained ad-
equately controlled in the majority of patients. 
The optimal frequency of monitoring has not been established yet. Obviously, there 
is a difference between episodes of uncontrolled asthma where asthma control is to be 
gained and episodes of adequately controlled asthma where asthma control must be 
maintained. The former episodes require a higher monitoring and feedback frequency 
than the latter episodes. 
Summary and general discussion 107
This theory is reflected by the reduced need for monitoring, observed in our study, 
once control of the disease had been achieved (10). 
Our algorithm was based on weekly measurements, since the ACQ captures the 
previous week. However, post-hoc analysis of our study data showed a good agreement 
between a single ACQ and the lowest level of asthma control in the previous month, 
with less than 11% unobserved loss in asthma control (11). In addition, daily symptom 
or lung function monitoring may be advised. In research settings, daily monitoring may 
be feasible and indicated in order to guide and evaluate treatment (3, 12). However in 
routine clinical practice it is questionable whether daily monitoring is necessary and ac-
cepted, especially by those patients with well controlled asthma (chapter 3). Therefore, 
the advantage of daily monitoring additional to weekly asthma control assessment as 
part of an internet-based self-management support program is questionable.  
understanding participation in internet-based self-management; users and 
health care professionals 
Users
Self-management of chronic diseases usually requires individual behaviour change. In 
contrast to traditional education, where patients are offered information and inhaler 
technique skills, self-management education teaches problem-solving skills and re-
quires collaborative care. Previously, researchers have studied intentions to participate 
in asthma self-management and found that patients with less structural barriers, such 
as no time, living too far away and financial barriers were twelve times more likely to 
participate (13). In addition to these well-known external barriers, we conducted a semi-
quantitative focus group study to elicit intrinsic barriers. The theory of planned behav-
iour, which assumes that attitude, social norm and self-efficacy expectations determine 
a person’s intention to perform a specific behaviour, was used as a theoretical framework 
(chapter 3). Of these three determinants, limited self-efficacy (i.e. perceived ability to 
perform a specific action in a specific situation), turned out to be the main barrier in 
current asthma management, particularly for those patients with uncontrolled asthma. 
These patients in particular expressed several benefits from internet-based asthma 
self-management: electronic monitoring and feedback; easily accessible information; 
e-mail communication; and an electronic action plan. These characteristic features of an 
internet-based program may also eliminate external barriers such as time and distance 
constraints.
Health care professionals
Not only users, but also health care professionals, should be encouraged to use these 
new technologies in order to make implementation succeed. Previous research suggests 
108 Chapter 7 
that health care professionals are resistant to adopt internet-based technologies into 
routine practice (14). At baseline, only 10 participants (5%) in our study reported to pos-
sess a written action plan, despite the availability of an effective asthma action plan for 
the Dutch primary care setting (15, 16), which seems to confirm physicians’ reluctance 
to incorporate asthma self-management plans. Nevertheless, 37 out of 43 general prac-
tices (86%) we approached consented to participate in our study. Participation was not 
time-consuming for the health care professionals in these practices, mainly because the 
study team organised the education sessions and our asthma nurse specialist took care 
of the web-based follow-up. Obviously, successful implementation of internet-based 
asthma self-management requires professional roles and ways of working to be rede-
fined including the delegation of particular tasks to other (medical) personnel, patients 
and carers (17).
the evidence-base; methodology, effectiveness and economic consequences
Methodology
How strong is the evidence of effectiveness of internet-based self-management in 
asthma? To answer this question, we have to consider the design and attitude of our trial. 
In contrast to explanatory trials, designed to test causal research hypotheses, our trial 
had a highly pragmatic attitude. Pragmatic trials are designed to help choose between 
options for care. Therefore, the choice of the design should maximise applicability of the 
trial results to usual care settings and are tested in a wide range of participants (18). Key 
features of pragmatic trials are the setting of a normal practice, little or no selection of 
participants beyond the clinical indication of interest, a flexibly applied intervention as 
it would be in normal practice and outcomes that are directly relevant to participants, 
healthcare practitioners and communities (19). In our trial, participants were recruited 
from routine practice settings and exclusion criteria were set to a minimum, which 
enhances generalisability. The outcomes were both patient-centred (e.g. asthma related 
quality of life, asthma control) (20) and relevant to the community and policy makers 
(utilities and costs). 
We applied important dimensions of methodological quality such as randomisation 
and concealment of allocation to the design of our trial. However, blinding of par-
ticipants and health care providers was not only impossible, but also not desirable. As 
opposed to explanatory trials, where blinding prevents belief in the effectiveness of the 
intervention from confounding the causal link between intervention and outcome, in 
pragmatic trials, as in the routine care setting, belief in or enthusiasm for an intervention 
may add to the effects of the intervention. Moreover, even in pragmatic trials, it is pos-
sible to support patient-centred outcomes with an objective source of data, in our case 
lung function (19).
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Obviously, a placebo self-management program was not available. Therefore, we 
had to use another comparator; either a written self-management program or usual 
physician-provided care. The latter comparator, usual care, was most appropriate for 
two reasons. First, our research question was whether internet-based self-management 
led to improved asthma-related outcomes compared to the current routine practice. 
This current practice has incorporated written self-management plans only to a very 
limited degree. Second, we aimed to conduct an economic analysis, which requires a 
comparator which is most relevant for the policy question being addressed (21). In our 
case this question concerned the economic evaluation of internet-based asthma self-
management against the current standard of care.
Effectiveness
We evaluated processes as well as clinical outcomes (chapter 4). Since the principal 
components of asthma self-management have been shown to be self-monitoring, 
education, drug treatment and medical review, we have focused on these 4 process 
outcomes. Self-monitoring has been discussed previously. Interestingly, the educational 
outcomes (knowledge, inhaler technique and adherence to medication) improved for 
both groups without differences between groups. This finding corresponds with a Co-
chrane review which showed that limited patient education did not appear to improve 
health outcomes in adults with asthma (22). The provision of asthma information may 
be a necessary, but not a sufficient condition for improved outcomes in asthma self-
management programs.
We found significant differences in process outcomes between the study groups with 
regard to medication changes. Participants in the internet group had twice as many 
treatment increases and almost twice as many treatment decreases as participants in the 
usual care group. This suggests that the frequent medication changes (undoubtedly the 
consequence of self-monitoring and treatment advice) is the key feature of successful 
internet-based self-management. The rise in inhaled corticosteroid use during the first 
3 months in which asthma outcomes improved markedly, was followed by a decrease in 
the next 9 months without deteriorating outcomes, which suggests that higher doses 
of inhaled corticosteroids are necessary to gain than to maintain asthma control and 
optimal asthma related quality of life.
The correlation between for instance lung function and quality of life has been shown 
to be weak (20, 23). Therefore, we evaluated patient-centred (Asthma Control Question-
naire (ACQ), Asthma Quality of Life Questionnaire (AQLQ)) and traditional outcomes 
(lung function, symptoms). The minimal important difference for the ACQ and AQLQ 
scores is 0.5 on a 7-point scale. However, it is important to realize that, although the 
mean difference between a treatment and a control is appreciably less than the smallest 
change that is important for the group as a whole, treatment may have an important im-
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pact on many patients (24). Our study showed that even with a mean difference in AQLQ 
of 0.38 at a group-level,  the proportion of participants with a clinical important benefit 
(>0.5) in the internet group (54%) was twice as high compared to the usual care group 
(27%). In other words, 4 patients need to participate in internet-based self-management 
in order to improve asthma related quality of life for 1 patient. Similarly, the ACQ clini-
cally improved in 48% versus 17%; number needed to treat is 3. Lung function (FEV1), 
as the only objective outcome, improved markedly, which support the validity of the 
patient-reported outcomes.
We did not observe any differences in the rate of exacerbations between the two 
groups. This may be due to three reasons. First, the self-management program did not 
have any impact on asthma exacerbations. Second, the self-management program did 
have impact on exacerbations, but the number of participants was too small to detect 
this effect. Our sample size calculation was not aimed at detecting a reduction in exac-
erbations, but an improvement in asthma related quality of life. Third, we defined an 
exacerbation as a deterioration in asthma that required emergency treatment or hospi-
talization or the need for oral steroids. These severe exacerbations occurred in only 21 
out of 200 patients (0.1 per patient per year) in our study. Defining mild exacerbations 
for instance as a fall in peak flow of 20% below the base-line value or awakening at night 
on two consecutive days would probably have resulted in more reported exacerbations 
(25). However, a definition of mild exacerbation would have required close, daily moni-
toring in both groups, which would highly have disturbed routine clinical practice in 
the usual care group. This was not our intention, so we refrained from interfering into 
daily routine care in order to identify mild exacerbations and only monitored severe 
exacerbations.  
Economic consequences
Studies on innovative treatment strategies should ideally be accompanied by an 
economic evaluation in order to justify its implementation in the health care system. 
Preferably, a cost-utility analysis is performed, which measures costs from a societal or 
health care perspective and utilities as a generic outcome measure. These measures al-
low comparison of the economic consequences of different treatment strategies across 
a wide range of health care problems (21). 
We performed a cost-utility analysis using data from our randomised, controlled trial 
and found a cost-utility ratio of $26700 per QALY (quality adjusted life year) (chapter 
6). Some issues regarding this result need to be addressed. First, the calculations were 
based on costs during the one-year trial. The fixed technological costs of software 
development constituted about one third of the intervention costs ($254 per patient). 
A longer time horizon is likely to reduce intervention costs by a third. Second, the cal-
culations were based on 101 participants. Use of the internet-based program by more 
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participants would substantially reduce intervention costs per patient. Third, costs of 
the intervention should be set off against the cost reduction by reduced health care pro-
vider contact. Either the participants in the internet-group were less in need for health 
care provider contacts, because of better asthma control, or face-to-face consultations 
were replaced by on-line asthma nurse contacts (chapter 4). The latter contacts were 
captured by the intervention costs. Fourth, it is remarkable that the differences in utili-
ties were not statistically significant, whereas the differences in most clinical outcomes 
were. Most likely, the EQ-5D as a generic preference-based instrument may be able to 
differentiate between the highest en lowest levels of asthma control, but may be less 
able to discriminate between moderate levels (26, 27).
The point estimates of both costs and utilities were rather uncertain. To quantify this 
uncertainty we used the net benefit approach, which allowed us to report the probabil-
ity that our intervention was cost-effective at certain willingness-to-pay thresholds (28). 
These willingness-to-pay thresholds are arbitrary and subject of debate. In the literature, 
a commonly cited value is $ 50000 per QALY (29). The probability that internet-based 
self-management was cost-effective at this threshold was 62%. This result provides a fair 
basis to investigate the possibility of implementing internet-based self-management 
support of asthma into routine clinical care. 
implications and directions for future research; internet, chronic disease, self-
management
Internet
The studies in this thesis have addressed the role of the internet in the delivery of an 
asthma self-management program. Patients have favourably accepted this innovation 
in health care technology. Importantly, internet is available for the majority of patients: 
eighty-seven percent of the population has internet access at home (30). 
The use of internet adds to, rather than replaces ways of communication in current 
health care practices. Asynchronous communication, i.e. the fact that patient and health 
care provider need not be present at the same time, facilitates contact with the health 
care provider. Moreover, email or private message contacts may be time-saving com-
pared to visits to the health care centre. 
Within several years, it will probably be possible for patients to interact with their 
medical information using web portals. Ideally, the portal is integrated into existing 
electronic medical records. Patients will be able to view (parts of ) their records and 
might be able to add information to their personal health record. In recent decades we 
have witnessed the evolution of e-banking and e-learning; now the ways are paved to 
implement interactive e-health technology into routine clinical practice. 
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Chronic disease
Not only asthma, but also other conditions such as COPD, diabetes, heart failure, depres-
sion, arthritis or inflammatory bowel syndrome may be suitable for self-management 
interventions. These diseases share the characteristics of being chronic with recurrent 
and episodic deteriorations, and the effectiveness of self-management programs has 
been demonstrated (31, 32). 
Patients often have co-morbid conditions: COPD may coexist with heart failure, 
diabetes with depression, and asthma with COPD. Moreover, drugs for different diseases 
may interact. This interaction may go unnoticed, as the number of health care providers 
increases with the number of co-morbid diseases and more than one medical record 
may exist without mutual communication between health care providers. This may im-
pair patient safety and quality of care. The challenge is to integrate existing and effective 
self-management programs into one comprehensive disease management program for 
each patient.
Self-management
Although our internet-based self-management program has proved to be effective and 
seems to provide value for money, several issues need to be considered (33).
Long-term effectiveness: The one-year results of our internet-based asthma self-
management program are promising and the benefits seem to outweigh the costs. 
But what are the long-term consequences of implementation into current routine care; 
will the benefits still outweigh the costs in the long run? Economic evaluations over an 
extended period of time, using modelling techniques wherever necessary, are needed 
to convince policy makers and health care insurers of the necessity to implement self-
management support programs for asthma or other chronic diseases into routine care. 
Targeting self-management: We have demonstrated the effectiveness of internet-
based self-management for asthma patients. At subgroup level we have been able to 
differentiate between patients who did and did not benefit from the program on the 
basis of current asthma control. Probably, other individual factors, such as self-efficacy 
or attitude, may predict the individual’s response to an internet-based self-management 
program. These factors should be identified in order to better target the self-manage-
ment intervention, and maximize its efficiency. 
Organizational issues: Well conducted trials and modelling studies are not sufficient 
to ensure successful implementation. Self-management programs need to fit seamlessly 
within routine daily practice. In the past decade, primary care has faced and facilitated 
the advent of nurse practitioners, who have been responsible for improved quality of 
care for patients with chronic diseases such as diabetes, asthma and COPD. With the 
introduction of internet-based self-management programs tasks of health care profes-
sionals and personnel again need to be redefined. Are health care professionals able, 
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willing and ready to adopt these programs? The new care system in 2006 introduced 
many new parties in the market. We now witness the rise of companies who develop 
and promote internet-based self-care programs and products, such as Personal Medi-
cal Records. These initiatives may add to the adoption of self-management programs, 
but financial and personal interests need to be considered. The future for telemedicine, 
including internet-based self-management support, is promising, but should go hand 
in hand with a careful evaluation of its consequences, both health-wise and financial, 
along with all parties involved.
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achtergrond
Astma is een aandoening van de luchtwegen en wordt gekenmerkt door een piepende 
ademhaling, kortademigheid, hoesten en soms een beknellend gevoel op de borst. 
De klachten zijn niet continu aanwezig, maar treden episodegewijs op. Patiënten met 
astma reageren versterkt op prikkels waarop mensen zonder astma niet reageren. Het 
gaat daarbij om allergische prikkels zoals huisstofmijt, honden, katten, gras- of boom-
pollen en om niet-allergische prikkels zoals mist, kou, rook of parfum. Dit fenomeen 
wordt bronchiale hyperreactiviteit genoemd.
De klinische kenmerken van astma zijn het gevolg van een ontstekingsproces in 
de longen. Door deze ontsteking treedt slijmvlieszwelling (oedeem) op, wordt meer 
slijm in de luchtwegen geproduceerd (hypersecretie) en trekken de spieren rondom de 
luchtwegen samen (bronchospasme). Dit ontstekingsproces veroorzaakt luchtwegver-
nauwing met de daarbij optredende klachten en symptomen.
Ruim 3% van de Nederlanders heeft astma. De diagnose wordt gesteld door middel 
van anamnese en lichamelijk onderzoek. Longfunctietesten, bij voorkeur spirometrie, 
ondersteunen de diagnose. Een spirometrisch onderzoek bestaat uit een geforceerde 
uitademing vanuit volledige inademing. De voor astma belangrijkste maat die zo 
verkregen wordt, is de FEV1 (forced expiratory volume in 1 second ofwel het éénsecon-
devolume). Wanneer de FEV1 na het toedienen van een luchtwegverwijdend middel 
meer dan 12% is toegenomen ten opzichte van de uitgangswaarde (reversibiliteit) 
dan ondersteunt dit de diagnose. De laatste jaren is het gebruik van spirometrie in de 
huisartspraktijk fors toegenomen. Ongeveer tweederde van de Nederlandse huisartsen 
beschikt momenteel over spirometrie. Indien spirometrie niet beschikbaar is, kan een 
piekstroommeter aanvullende waarde hebben. De piekstroom is de maximale volu-
mestroom bij een geforceerde uitademing vanuit volledige inademing. Toegenomen 
reversibiliteit of variabiliteit (het verschil tussen piekstroomwaarden op verschillende 
dagen of binnen één dag) ondersteunen de diagnose. 
Behalve voor het stellen van de diagnose astma worden FEV1- en piekstroommetingen 
ook gebruikt om de behandeling te evalueren. Een toename van de longfunctieparame-
ters en een afname in reversibiliteit of variabiliteit duiden op een betere astmacontrole. 
behandeling 
De behandeling van astma richt zich op het verbeteren van de huidige astmacontrole 
en op het voorkomen van complicaties in de toekomst. De behandeldoelen voor astma-
controle bestaan uit het verminderen van klachten en symptomen, het minimaliseren 
van het gebruik van kortwerkende luchtwegverwijders en het optimaliseren van de 
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longfunctie. Bij het voorkomen van complicaties in de toekomst gaat het om het voor-
komen van exacerbaties, het behoud van een goede longfunctie op de lange termijn en 
het voorkomen van bijwerkingen van medicatie.
Belangrijke componenten van de behandeling van astma zijn 1) voorlichting en 
niet-medicamenteuze adviezen vanuit een goede arts-patiëntrelatie, 2) metingen van 
astmacontrole, 3) medicamenteuze therapie en 4) reguliere medische controle. Juist 
bij zelfmanagement van astma zijn dit de belangrijkste pijlers van de behandeling. 
Kenmerkend voor zelfmanagement is de actieve betrokkenheid van de patiënt bij zijn 
behandeling. Dit kan door het verrichten van zelfmetingen van astmacontrole (klachten 
en longfunctie) en het gebruik van een vooraf opgesteld behandelplan. De patiënt 
maakt aan de hand van het behandelplan zelf keuzes in zijn behandeling en wordt niet 
zozeer behandeld, maar eerder begeleid.
dit Proefschrift
Hoewel nationale en internationale richtlijnen de gunstige effecten van astma-zelf-
management onderschrijven en professionals aanbevelen patiënten te ondersteunen 
bij zelfmanagement, wordt hier in de praktijk weinig gebruik van gemaakt. Een van de 
oorzaken is dat bestaande schriftelijke behandelplannen als bewerkelijk en tijdrovend 
worden gezien. Zowel patiënten als zorgverleners zijn daardoor niet erg enthousiast over 
het gebruik van dergelijke schriftelijke astmabehandelplannen. Met de komst van nieuwe 
media als het internet is het mogelijk om deze behandelplannen niet alleen op papier, 
maar ook elektronisch aan te bieden. Dit biedt mogelijk voordelen ten aanzien van de 
voorlichting, communicatie en het gebruik van zelfmetingen en zelfbehandelplannen, 
maar de opbrengst is niet eerder onderzocht. Dit proefschrift beschrijft onderzoeken naar 
verschillende aspecten van zelfmanagement bij astma via internet: compliantie en be-
trouwbaarheid van elektronische piekstroommetingen, barrières bij huidige astmabehan-
deling en voordelen, effectiviteit en kosten-effectiviteit van zelfmanagement via internet. 
compliantie en betrouwbaarheid van elektronische piekstroommetingen
Compliantie is de mate waarin patiënten het advies van hun zorgverlener opvolgen. 
In het geval van geschreven piekstroomdagboeken blijken patiënten met astma vaak 
niet dagelijks een piekstroom te blazen en te noteren, ook als de zorgverlener daar om 
vraagt. De compliantie laat dus te wensen over. Ook zijn de genoteerde piekstroom-
waarden vaak niet betrouwbaar. Patiënten schrijven de waarde van de piekstroommeter 
verkeerd over of verzinnen zelf een waarde. Het is onbekend wat de compliantie en 
betrouwbaarheid van elektronische piekstroommetingen zijn, waarbij de patiënt de 
piekstroomwaarden rapporteert via SMS of via een website.
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Onderzoeksvraag
Hoe is de compliantie en betrouwbaarheid van elektronische piekstroommetingen?
Methode
We vroegen 97 adolescenten met astma tussen de 12 en 17 jaar om gedurende 4 weken 
dagelijks een piekstroom te blazen en de piekstroomwaarde te rapporteren via SMS of 
via een speciaal ontworpen website. Direct na het rapporteren ontvingen de deelnemers 
een ontvangstbericht met informatie over hun piekstroomwaarde als percentage van de 
persoonlijk beste waarde. De deelnemers waren niet op de hoogte dat de elektronische 
piekstroommeter de waardes in het geheugen opsloeg.
Resultaten
De compliantie bedroeg in de eerste week ruim 90% en daalde tot ruim 80% in de vierde 
week. Het percentage correct gerapporteerde metingen was 80% over de hele periode, 
ruim 90% in de eerste week dalend naar bijna 70% in de laatste week. Twee procent van 
alle gerapporteerde metingen bleek te zijn verzonnen. 
Conclusie
De compliantie en betrouwbaarheid van elektronische piekstroommetingen zijn hoog 
gedurende een periode van 4 weken. Dit onderzoek ondersteunt de invoer van elektro-
nische longfunctiemetingen bij zelfmanagementprogramma’s voor adolescenten met 
astma via internet.
barrières bij huidige astmabehandeling en voordelen van zelfmanagement via 
internet
Hoewel zelfmanagement bij astma een effectieve behandelstrategie is, maken weinig 
patiënten en zorgverleners gebruik van zelfmanagementprogramma’s. Patiëntfactoren 
die uit eerder onderzoek van belang zijn gebleken voor deelname aan dergelijke pro-
gramma’s zijn tijd en afstand tot de zorgverlener. Weinig is echter bekend over de rol van 
intrinsieke barrières zoals negatieve attitude en beperkte eigen-effectiviteit. Daarnaast 
is niet bekend welke mogelijke voordelen zelfmanagement via internet biedt in de ogen 
van adolescenten (met goed of slecht gecontroleerd astma).
Onderzoeksvragen
Wat zijn intrinsieke barrières bij de behandeling van astma?




De patiënten die hadden deelgenomen aan het hiervoor beschreven onderzoek naar 
elektronische piekstroommetingen werden na de periode van 4 weken zelfmetingen 
uitgenodigd voor focusgroepinterviews. We vormden 8 groepen (in totaal 35 deelne-
mers) en stratificeerde deze groepen naar leeftijd, geslacht en mate van astmacontrole.
Resultaten
Beperkte eigen-effectiviteit, dat wil zeggen vertrouwen in eigen kunnen, was de 
belangrijkste barrière bij de behandeling van astma bij patiënten met slecht gecon-
troleerd astma. De adolescenten gaven meerdere voordelen aan van zelfmanagement 
via internet: de haalbaarheid van elektronische zelfmetingen, toegankelijke informatie, 
e-mailcommunicatie en het gebruik van een onlinebehandelplan. De groep met slecht 
gecontroleerd astma zag het nut in van zelfmanagement via internet en was er klaar 
voor om dit in het dagelijks leven in te passen. De groep met goed gecontroleerd astma 
noemde dit niet.
Conclusie
Beperkte eigen-effectiviteit is de belangrijkste intrinsieke barrière bij de behandeling 
van astma. Voordelen van zelfmanagement via internet zijn de elektronische zelfmetin-
gen, toegankelijke informatie, e-mailcommunicatie en het gebruik van een onlinebe-
handelplan. Zelfmanagement via internet dient gericht te zijn op patiënten met slechte 
astmacontrole. 
effectiviteit van zelfmanagement bij astma via internet
Bij meer dan de helft van de patiënten met astma zijn klachten en symptomen 
onvoldoende gecontroleerd. In de praktijk komen deze patiënten vaak niet voor con-
trole op het spreekuur. Internet lijkt een aantrekkelijk medium om zelfmanagement 
van patiënten met astma te ondersteunen. Onderzoek naar zelfmanagement van astma 
via internet heeft op de korte termijn gunstige resultaten laten zien wat betreft ast-
macontrole, longfunctie en kwaliteit van leven. Langetermijnstudies naar zelfmanage-
ment van astma zijn nog niet verricht. We ontwikkelden met behulp van internet een 
zelfmanagementprogramma voor coaching van volwassen patiënten met astma. Het 
programma omvatte alle essentiële aspecten van zelfmanagement: zelfmetingen met 
daaraan gekoppelde behandeladviezen (behandelplan), online educatie en coaching 
door een longverpleegkundige.
Onderzoeksvraag
Is zelfmanagement via internet gedurende 1 jaar effectief wat betreft procesuitkomsten 
en klinische uitkomsten bij astma?
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Methode
Via 37 huisartspraktijken en een polikliniek longziekten rekruteerden we 200 astma-
patiënten met een voorschrift van inhalatiecorticosteroïden gedurende tenminste 3 
maanden in het afgelopen jaar en toegang tot internet. Patiënten werden at random 
toegewezen aan de internetgroep (n = 101) of de gebruikelijkezorggroep (n = 99). 
Deelnemers in de internetgroep verrichtten wekelijks zelfmetingen van astmacontrole 
via internet en kregen onlinebehandeladvies, educatie en coaching door een longver-
pleegkundige. Procesuitkomsten waren kennis, inhalatietechniek, therapietrouw, aantal 
contacten met zorgverleners en aantal medicatieveranderingen. Klinische uitkomsten 
waren astmagerelateerde kwaliteit van leven, astmacontrole, klachtenvrije dagen, long-
functie en tijd tot eerste exacerbatie.
Resultaten
De kennis over astma en inhalatietechniek verbeterde iets in beide groepen, maar er 
was geen verschil tussen de 2 groepen. Therapietrouw bleef in beide groepen hetzelfde. 
Het aantal doktersbezoeken vanwege astma was in de internetgroep iets meer dan 1 
per patiënt en bijna 2 per patiënt in de gebruikelijkezorggroep. Patiënten in de internet-
groep hadden ongeveer tweemaal zo vaak een verandering in medicatie dan patiënten 
in de gebruikelijkezorggroep. 
Astmagerelateerde kwaliteit van leven verbeterde meer in de internetgroep dan 
in de gebruikelijkezorggroep. In de internetgroep had 54% een klinisch relevante 
verbetering ten opzichte van 27% in de gebruikelijkezorggroep. Ook astmacontrole 
verbeterde meer in de internetgroep dan in de gebruikelijkezorggroep. Na 12 maanden 
was het percentage klachtenvrije dagen ruim 10% hoger in de internetgroep dan in de 
gebruikelijkezorggroep en was de longfunctie in eerstgenoemde groep beter. Er was 
geen verschil tussen de groepen wat betreft tijd tot eerste exacerbatie.
Conclusie
Vergeleken met gebruikelijke zorg verbeteren de kennis over astma, inhalatietechniek 
en therapietrouw niet door zelfmanagement via internet. Wel vermindert het aantal 
doktersbezoeken en stijgt het aantal aanpassingen van medicatie. Zelfmanagement 
via internet verbetert de astmagerelateerde kwaliteit van leven, astmacontrole, aantal 
klachtenvrije dagen en longfunctie. De tijd tot de eerste exacerbatie verandert niet. 
Zelfmanagement bij astma via internet is effectief en biedt nieuwe mogelijkheden in de 
behandeling van astma.
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Verschil in effectiviteit tussen patiënten met verschillende mate van 
astmacontrole bij de start
Het effect van zelfmanagement via internet op astmacontrole dat gevonden werd in 
bovenstaand onderzoek was weliswaar statistisch significant, maar voor de groep als 
geheel niet erg groot. In de huidige studie bestudeerden we het effect op medicatie-
gebruik en astmacontrole van zelfmanagement via internet voor drie subgroepen van 
astmacontrole bij de start van het onderzoek (baseline): goed gecontroleerd, matig 
gecontroleerd en slecht gecontroleerd astma.
Onderzoeksvraag
Wat is het effect op astmacontrole en medicatiegebruik van zelfmanagement via inter-
net voor groepen met verschillende mate van astmacontrole op baseline?
Methode
De patiënten uit het hiervoor beschreven gerandomiseerde onderzoek deelden we 
in in de groepen goed, matig en slecht gecontroleerd astma op baseline. Vervolgens 
onderzochten we bij deze drie groepen gedurende 1 jaar de veranderingen in medica-
tiegebruik en astmacontrole.
Resultaten
Astmacontrole was verbeterd in de groepen met matig en slecht gecontroleerd astma, 
maar niet in de groep met goed gecontroleerd astma. In de groep met slecht gecon-
troleerd astma was het gebruik van inhalatiecorticosteroïden in de eerste 3 maanden 
toegenomen. Na een jaar was er in geen van de 3 groepen een statistisch significante 
verandering in medicatiegebruik.
Conclusie
Zelfmanagement via internet verbetert de astmacontrole bij patiënten met matig en 
slecht gecontroleerd astma op baseline. Medicatiegebruik wordt toegesneden op de 
behoefte van iedere individuele patiënt.
kosten-effectiviteit van zelfmanagement bij astma via internet
In de bovenstaande twee onderzoeken hebben we laten zien dat zelfmanagement bij 
astma via internet een effectieve behandelstrategie is om klachten en symptomen te 
doen verminderen en de astmagerelateerde kwaliteit van leven te verbeteren. Nieuwe 
behandelstrategieën vereisen behalve een evaluatie van de effectiviteit ook een evalu-
atie van de kosten-effectiviteit om te bepalen of de gunstige resultaten bereikt worden 
tegen acceptabele kosten. Een kosten-effectiviteitsanalyse helpt richtlijnontwikkelaars, 
beleidsmakers en verzekeraars om de nieuwe behandelstrategie al dan niet aan te 
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bevelen of te vergoeden. Daarom verrichtten wij een kosten-effectiviteitsanalyse van 
zelfmanagement bij astma via internet.
Onderzoeksvraag
Is zelfmanagement bij astma via internet kosten-effectief vergeleken met de gebruike-
lijke zorg?
Methode
De data voor deze analyse werden verkregen via het gerandomiseerde onderzoek bij 
200 patiënten met astma, beschreven in de vorige twee onderzoeken. De effectiviteit in 
deze analyse betrof het aantal gewonnen QALYs. Een QALY (quality adjusted life years) 
is een maat die zowel de kwaliteit als de kwantiteit van leven omvat. Een gewonnen 
levensjaar in perfecte gezondheid wordt gewaardeerd met 1 QALY, maar wanneer een 
levensjaar wordt gewonnen dat gepaard gaat met ziektelast dan is de QALY kleiner dan 
1. De kosten van zelfmanagement bij astma via internet bestonden uit de kosten voor de 
interventie, de kosten voor zorggebruik (zoals doktersbezoek en gebruik van medicatie) 
en productiviteitsverlies door absentie van werk. We berekenden de waarschijnlijkheid 
dat zelfmanagement bij astma via internet kosten-effectief is vanuit maatschappelijk 
perspectief en vanuit het perspectief van de gezondheidszorg. 
Resultaten
Ten opzichte van gebruikelijke zorg was er een lichte toename in QALYs bij zelfmanage-
ment via internet. Deze toename was niet statistisch significant. De kosten voor de 
interventie waren $254 per persoon per jaar. De kosten voor zorggebruik waren $217 
lager in de internetgroep dan in de gebruikelijkezorggroep, met name vanwege min-
der contacten met zorgverleners. Wanneer de maatschappij bereid is om voor 1 QALY 
$50000 te betalen (willingness to pay) dan is de waarschijnlijkheid dat zelfmanagement 
kosten-effectief is ten opzichte van gebruikelijke zorg 62% vanuit maatschappelijk 
perspectief en 82% vanuit het perspectief van de gezondheidszorg. 
Conclusie
Zelfmanagement bij astma via internet is waarschijnlijk kosten-effectief. Implementatie 




• De compliantie en betrouwbaarheid van elektronische piekstroommetingen zijn 
hoog gedurende een periode van 4 weken.
• Beperkte eigen-effectiviteit is de belangrijkste intrinsieke barrière bij de behandeling 
van astma. 
• Voordelen van zelfmanagement via internet zijn de elektronische zelfmetingen, 
toegankelijke informatie, e-mailcommunicatie en het gebruik van een onlinebehan-
delplan.
• Vergeleken met gebruikelijke zorg verbeteren de kennis over astma, inhalatietech-
niek en therapietrouw niet door zelfmanagement via internet.
• Zelfmanagement via internet verbetert de astmagerelateerde kwaliteit van leven, 
astmacontrole, aantal klachtenvrije dagen en longfunctie, maar de tijd tot de eerste 
exacerbatie verandert niet. 
• Zelfmanagement via internet verbetert astmacontrole bij patiënten met matig en 
slecht gecontroleerd astma op baseline.  Medicatiegebruik wordt toegesneden op de 
behoefte van iedere individuele patiënt.
• Zelfmanagement bij astma via internet is waarschijnlijk kosten-effectief.
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